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ABSTRACT 
 
The emerging field of micro total analysis system (µTAS) powered by microfluidics is expected 
to revolutionize miniaturization and automation for point-of-care-testing systems which require 
quick, efficient and reproducible results. In the present study, a PDMS based µTAS has been 
developed for rapid, multi-purpose, impedance based detection of biomolecules. The major 
components of the µTAS include a micropump, micromixer, magnetic separator and 
interdigitated electrodes for impedance detection. Three designs of pneumatically actuated 
PDMS based micropumps were fabricated and tested.  Based on the performance test results, one 
of the micropumps was selected for integration. The experimental results of the micropump 
performance were confirmed by a 2D COMSOL simulation combined with an equivalent circuit 
analysis of the micropump.  Three designs of pneumatically actuated PDMS based active 
micromixers were fabricated and tested. The micromixer testing involved determination of 
mixing efficiency based on the streptavidin-biotin conjugation reaction between biotin 
comjugated fluorescent microbeads and streptavidin conjugated paramagnetic microbeads, 
followed by fluorescence measurements.  Based on the performance test results, one of the 
micromixers was selected for integration.  The selected micropump and micromixer were 
integrated into a single microfluidic system. The testing of the magnetic separation scheme 
involved comparison of three permanent magnets and three electromagnets of different sizes and 
magnetic strengths, for capturing magnetic microbeads at various flow rates. Based on the test 
results, one of the permanent magnets was selected. The interdigitated electrodes were fabricated 
on a glass substrate with gold as the electrode material.  The selected micropumps, micromixer 
and interdigitated electrodes were integrated to achieve a fully integrated microfluidic system. 
The fully integrated microfluidic system was first applied towards biotin conjugated fluorescent 
microbeads detection based on streptavidin-biotin conjugation reaction which is followed by 
impedance spectrum measurements. The lower detection limit for biotin conjugated fluorescent 
microbeads was experimentally determined to be 1.9 x 10
6
 microbeads. The fully integrated 
microfluidic system was then applied towards immuno microbead based insulin detection. The 
lower detection limit for insulin was determined to be 10
-5
M. The total detection time was 20 
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1.1 Microelectromechanical Systems (MEMS) 
MEMS refers to devices that have a characteristic length scale between 1 µm and 1 mm. MEMS 
devices usually combine electrical and mechanical components and are fabricated using 
integrated circuit batch-processing technologies. These devices have the ability to sense, control 
and actuate on the micro scale. Most of the MEMS fabrication methods were developed in the 
1970s and 1980s by the silicon microprocessor industry. In 1975, the first analytical MEMS 
device fabricated on silicon, a gas chromatographic analyzer was reported [1]. This gas 
chromatograph was able to separate a simple mixture of compounds in a few seconds. Most of 
the research work during the period from 1975 - 1989 was focused on the microfabrication of 
silicon based components such as micropumps [2], microvalves [3], and Ion-Sensitive Field-
Effect (ISFET) chemical sensors [4]. Some of the early MEMS components that were used in 
commercial products and applications include accelerometers used to control airbag deployment 
in vehicles, pressure sensors for medical applications, and inkjet printer heads. In 1990, the 
silicon-based analyzers re-emerged with a miniaturized open-tubular liquid chromatograph on a 
silicon wafer [5]. In 1990s, the MEMS industry diversified and devices were fabricated for 
chemical, biological, and biomedical applications which led to the creation of a new discipline 
called microfluidics. Microfluidic devices include micrometer sized channels, chambers, filters 
and other components to manipulate sub-μL to μL volumes of samples and reagents. Fluid flows 
in micro devices are significantly different from their macroscopic counterparts. The surface to 
volume ratio for a machine with a characteristic length of 1 m is 1 m
-1
, while that for MEMS 




. The million fold increase in the surface to volume ratio 
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substantially affects the transport of mass, momentum and energy through the surface. The 
MEMS component market is expected to reach $20B in 2016 [6]. 
1.2 Microfabrication 
The two most common methods for production of MEMS devices are surface micromachining 
and bulk micromachining. Surface micromachining is an additive process. It consists of a series 
of deposition, patterning and etching of thin films with thickness typically in the range of 1-100 
μm. One of the crucial steps in surface micromachining is the selective removal of the 
underlying film (sacrificial layer) without damaging the overlying films (structural layer). Many 
commercial MEMS products such as airbag sensors apply this fabrication technique. Bulk 
micromachining is a subtractive fabrication method which involves patterning and etching of the 
substrate materials such as silicon, quartz, SiC, GaAs, and glass. The etching can be carried out 
using orientation dependent (anisotropic) or orientation independent (isotropic) wet etchants. If 
the process requires a dry environment, deep reactive ion etching (DRIE), a Bosch process 
invented and patented by Robert Bosch GmbH in Reutlingen, Germany, can be used to pattern 
silicon based materials. DRIE is a two-step process consisting of an etching and a passivation 
cycle. In the etching cycle, silicon is removed using SF6 and in the passivation cycle, C4F8 is used 
to produce a very thin layer of fluorocarbon polymer to passivate the side walls. In the following 
etch cycle the polymer film at the bottom of the trench is removed by ion bombardment, while 
the side walls are protected by the polymer film. The two step process is repeated until the 
desired depth is attained. With DRIE, microfeatures with high aspect ratios can be fabricated. 
Bulk and surface micromachining are limited to high stiffness semiconductor materials with 
Young’s modulus ~ 100 GPa [7]. The stiffness of the material is important as it affects the forces 
generated by the micro actuators.  Furthermore, for active devices requiring multiple layers of 
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materials, adhesion between layers is of great concern. For bulk micromachining, complicated 
wafer bonding techniques are required to produce multilayer structures. For surface 
micromachining, thermal stress between layers limits the total thickness to ~ 20 μm [8]. Bulk and 
surface micromachining require clean room environment and fine control of process conditions 
in order to realize devices with good yields. 
Micromolding is suitable for large scale production of polymeric devices. The most common 
techniques in micromolding are injection molding and compression molding. In injection 
molding, metal mold inserts are used as a replica master and the molding process is carried out at 
temperatures above the glass transition temperatures of amorphous thermoplastics such as 
polymethylmethacrylate (PMMA) and polyamide. Compression molding or hot embossing is a 
technique where the desired structure is pressed under vacuum into a semi-finished polymer 
material at an elevated temperature above the glass transition temperature. LIGA (lithographie 
galvanoformung abformtechnik) is a fabrication technique involving X-Ray lithography, 
electroforming, and a micromolding process [9]. Metal or plastic microstructures with straight 
sidewall and high aspect ratio (over 100:1) can be fabricated using LIGA.  
Soft lithography is gaining popularity as an alternative to photolithography and is useful for 
prototyping of devices useful for applications in life sciences research. In soft lithography, a 
topologically patterned stamp (or mold) is used to transfer a pattern to a substrate [10].  There are 
two types of soft lithography [10]: 1) the replication of a pattern defined in a soft (elastomeric) 
stamp into organic material or onto the surface of metals, ceramics etc. 2) replication of a pattern 
defined in a hard stamp into a thin layer of soft organic molecules (e.g. thermoplastic polymers). 
The second type of soft lithography has been widely used in recent times to fabricate 
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microfluidic devices with SU-8 structures on silicon wafer as a mold and polydimethylsiloxane 
(PDMS) as the soft structural material for the device.  
Soft lithography provides researchers with rapid prototyping from design to prototype in 24-48 
hours using equipment found in most scientific laboratories. The tolerant process conditions of 
soft lithography permits the devices to be produced in ambient laboratory conditions without a 
need for clean room environment. The capabilities of soft lithography are compatible with 
requirement of devices in biology and biochemistry. It is easier to produce multi layered devices 
with soft lithography when compared to conventional micromachining.  Furthermore, since the 
multilayer devices produced by soft lithography are monolithic, thermal stresses are avoided and 
interlayer adhesion failures are reduced.   
1.2.1 Fabrication Materials for Microfluidic Devices 
Microfluidic devices have been fabricated from various materials which include silicon, glass, 
ceramic, hard plastics and elastomers. In recent years, ever since Whitesides’ group introduced 
the soft-lithography technique [11], PDMS casting on SU-8 mold has been extensively used in 
various microfluidic research activities. There has been an increasing interest in rapidly 
prototyping microfluidic systems in PDMS as an alternative to glass and silicon based systems. 
PDMS micro-molding techniques have been used to fabricate microfluidic systems by many 
groups [12-15]. PDMS is a low-cost material when compared to traditional micro-fabrication 
materials, such as silicon and glass. A major advantage of PDMS is that once a master mold is 
fabricated, multiple devices can be rapidly cast without the need for a clean room environment. 
PDMS processes are simple and rapid when compared to traditional etching and bonding 
approaches. The patterned PDMS layers can be stacked to make multilayered device structures. 
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PDMS rapid prototyping enables device design modifications and optimization to be completed 
in a shorter time with minimum cost. PDMS is self-releasing and leaves very little residue on a 
mold, thus allowing the mold to be reused for a long time.  
Some of the other advantages of PDMS include: 
1. Excellent optical properties (with transparency down to 280 nm) for optical detection 
schemes. 
2. It can be thermally cured at low temperatures (at room temperature in 24 hours and at 
80ºC in 2 hours).  
3. Features on the micron scale can be reproduced with high resolution. 
4. Non-toxic and biocompatible. 
5. Its surface properties can be easily modified to be hydrophobic or hydrophilic by well-
established surface treatment protocols. 
6. Its elastic properties can be easily altered by changing the mixing ratios of the base and 
curing agent of the pre-polymer. 
SYLGARD 184 Silicone Elastomer Kit (Dow Corning, Midland, MI) is widely used to prepare 
PDMS. The SYLGARD 184 PDMS kit consists of a curing agent and prepolymer which can be 
mixed in a 1:10 ratio and thermally cured to obtain PDMS. Traditionally, thick (> 100 μm) and 
high aspect ratio microstructures have been fabricated using LIGA [16], microstereolithography 
[17] and DRIE [18] processes. These techniques require complex and expensive equipment that 
are not readily accessible to small scale laboratory facilities. The application of SU-8 
(MicroChem Corp., Newton, MA) to fabricate thick microstructures for MEMS applications has 
attracted lot of interest [19] in the recent years. SU-8 is a high contrast, negative,  epoxy-based 
line of near-ultraviolet (UV) radiation-sensitive photoresists with suitable chemical and 
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mechanical properties that can be used to fabricate high aspect ratio microstructures with near-
vertical side walls in a single photolithographic step [19]. A developed SU-8 structures is 
thermally (up to 200 °C) and chemically stable,  making them well suited for fabricating 
permanent structures such as pixel walls, fluidic channels, nozzles, micro arrays and spacers. 
1.3 Miniaturization of Diagnostic Assays 
A wide variety of classical, macroscopic liquid handling systems for performing analytical and 
diagnostic assays have been in use for many decades. Miniaturization of the macroscopic liquid 
handling system has become a popular trend in the last few decades and has led to a new class of 
microanalyzers. The common feature of all these devices is the miniaturization of an analytical 
process or part of the analytical process into a device built on a small substrate of glass, plastic or 
silicon. 
There are several compelling reasons for the miniaturization of analyzers. The scaling effects due 
to decreased length scales allow for new applications that are not achievable in macroscopic 
liquid handling systems. Miniaturization makes the analytical processes cost effective by 
reducing the volume of reagents used per assay (in the order of nano to pico liter) when 
compared to the traditional analysis. In case of drug discovery applications, where there is a 
limited amount of drug compound to be tested, a reduction in the volume of the reagents, allows 
more tests to be performed on that drug compound. The reduction in footprint of each individual 
test enables a higher degree of parallelization within a small space. A key example is parallel 
reactions in hundreds of thousands of individual wells with picoliter volumes and minimum 
reagent consumption for genome sequencing [20]. The chemical reaction rate is high and the 
response time of the device is fast due to the small scale of the devices and smaller volumes of 
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the samples. Due to decreasing length scales, surface phenomenon such as capillary forces and 
surface charges in miniaturized devices becomes dominant. This permits purely passive liquid 
actuation based on capillary forces in the lateral flow assays also known as capillary test strips. 
Another outcome is the onset of a laminar flow at low Reynolds number in small channels. This 
enables the creation of well-defined and stable liquid-liquid interfaces. The use of multiple 
laminar streams in a microfluidic channel to deliver membrane permeable molecules to selected 
subcellular microdomains has been reported [21]. Another important advantage of 
miniaturization is the ability to integrate all the steps of a multi-step analytical process on to a 
single device. It is possible to design a microsystem which can be used to perform different tasks 
like sample addition, processing and analysis, all on a microchip that is 2 cm × 2 cm or smaller 
[22]. This concept is very similar to the integrated electronic circuits, where millions of 
individual components are integrated into a single chip. Some of the other helpful properties of 
small assay volumes are fast thermal reaction and low power consumption for liquid 
manipulation and thermal control [23]. This can speed up assays such as PCR that require a 
thermocycling step. However, miniaturization has some disadvantages. The small size of the 
microchip can make their handling difficult. This can only be overcome by packaging the 
microchip into a larger holder or by mounting the microchip onto a platform.  A drastic reduction 
in the sample size can sometimes make the sample a bad representative of the specimen such as 
non-homogenous biological specimens that contain a diversity of constituents like cells, proteins, 
etc. This problem can be overcome by developing flow-through sampling in which large 
volumes of the sample are transported through a low volume microanalyzer. Another problem 
associated with sample volume reduction is the detection limit. If the concentration of the analyte 
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is low in the specimen, a volume reduction can decrease the quantity of the analyte detectable by 
the microanalyzer. 
1.4 Microfluidic System Designs 
A microfluidic system provides a set of fluidic unit operations, which provide a generic and 
consistent way for miniaturization, integration, automation and parallelization of (bio-) chemical 
processes [23]. Microfluidic systems can be broadly classified according to the main liquid 
propulsion principle as shown in Figure 1.1. 
 
Figure 1.1 Microfluidic systems classified according to their main liquid propulsion principle 
1.4.1 Capillary 
Lateral flow (LF) tests are commonly known as test strips where the sample liquids are driven by 
capillary forces. The liquid flow is controlled by the wettability and feature size of the 
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microstructured substrate. All the required chemicals are pre-stored within the test strip. The test 
results are optical signals and are usually implemented as a color change in the detection area 
that is visible to the naked eye.  
1.4.2 Pressure Driven 
In linear actuated devices (LAD), liquid movement is controlled by mechanical displacements of 
a plunger. Liquid flow is usually restricted to a single direction without any branches or alternate 
flow pathways. In these devices, the calibration liquids and buffers are usually pre-stored in 
pouches.  A pressure driven laminar flow (PDLF) system is characterized by a liquid transport 
due to pressure gradients. Typically, this creates stable laminar flow profiles within the 
microchannels. There are a wide range of external and internal pressure sources such as syringe, 
pumps or micropumps, gas expansion principles, and pneumatic displacement of a flexible 
membrane that can be used to implement a PDLF. A pressure driven microfluidic system has 
been implemented in the present study. 
The samples and reagents are usually injected into the chip inlets, either in a batch or a 
continuous mode. PDLF offers predictable velocity profiles and controllable diffusion mixing. 
Microfluidic large scale integration (MLSI) describes a microfluidic channel circuitry with chip-
integrated microvalves based on flexible membranes between a liquid-guiding layer and a 
pneumatic control-channel layer. The microvalves open and close according to the pneumatic 
pressure applied to the control-channels. Complex units such as micropumps, mixers, and 
multiplexers can be designed by combining several microvalves on one single chip. The MLSI 
platform developed in 1993 [24] when combined with soft lithography techniques enabled the 
monolithic fabrication of all necessary fluidic components within one single elastomer material 
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such as PDMS. Segmented flow microfluidics (SFM) transport small liquid plugs and/or droplets 
immersed in a secondary immiscible continuous phase (gas or liquid) within closed microfluidic 
channels [23].  The plugs/droplets are typically in the picoliter to microliter volume range and 
can be transported by pressure gradients generated by external pressure sources. The 
plugs/droplets can be merged, split, sorted, and processed.  
1.4.3 Other Systems 
In centrifugal microfluidics (CM), all processes are controlled by the frequency protocol of a 
rotating microstructured substrate [23]. The forces involved in the liquid transport include 
centrifugal force, Euler force, Coriolis force and capillary force. All the assays are implemented 
as a sequence of liquid operations in a radially inward to outward direction. In electrokinetic 
(EK) system, microfluidic operations are performed by electric fields acting on electric charges 
or electric field gradients acting on electric dipoles [23].  Several EK effects such as 
electroosmosis (EO), electrophoresis (EP), dielectrophoresis (DEP) and polarization can be 
superimposed on each other. EO can be used to transport bulk liquid, while other effects can be 
used to separate different types of molecules within the bulk liquid. Electrowetting (EW) systems 
use droplets on a hydrophobic surface that contain one- or two- dimensional array of individually 
addressable electrodes. The droplets can be generated, transported, split, merged and processed 
by changing the voltage between neighboring electrodes.  The surface acoustic wave (SAW) 
system uses droplets residing on a hydrophobic solid support in a gaseous environment (air) and 
the microfluidic unit operations are mainly controlled by acoustic shock waves travelling on the 
surface of the solid support [23]. The shock waves are generated by a piezoelectric transducer 




Microorganisms such as bacteria and virus are an integral part of life on earth. Some of these 
microorganisms are pathogenic in nature and can cause disastrous effects on human health. The 
detection of pathogenic bacteria and viruses is a key to the prevention and identification of many 
health problems. Similarly, the ability to detect physiologically significant biomolecules in the 
body with high sensitivity and specificity offers a powerful prospect in early diagnosis and 
treatment of diseases. Early detection and diagnosis can significantly reduce the cost of patient 
care associated with advanced stages of many diseases. Figure 1.2 [25] shows that the food 
industry [26-27] water and environment quality control [28-29] and clinical diagnosis [30] 
constitute over two thirds of all research activities. The food industry dominates the need for 
pathogen detection. There are tough legislations in the food industry, where a failure to detect a 
contamination can lead to widespread public health damages. More than 200 known diseases are 
transmitted through food [31] and the symptoms of foodborne illnesses range from mild 
gastroenteritis to life-threatening neurologic, hepatic, and renal syndromes. It has been reported 
[32] that foodborne diseases cause approximately 76 million illnesses, 325,000 hospitalizations, 
and 5,000 deaths in the United States each year. The USDA estimates that $2.9 - $6.7 billion is 





Figure 1.2 Distribution, by industry of application, of the relative number of works appeared in 
the literature on detection of pathogenic bacteria  
 
 
The cost for patient care at advanced stages has been estimated to be $75 billion [34] and $90 
billion [35] for cancer and diabetes, respectively. At present, cancer detection can be done by 
monitoring the concentration of certain antigens present in the bloodstream or other bodily 
fluids, or through tissue examinations. Diabetes is monitored by determining the glucose 
concentrations in the blood over time. But despite their widespread clinical use, these diagnostic 
techniques have a number of limitations. In order to diagnose and monitor various diseases in a 
patient, it is a common practice to examine blood/urine samples and perform various 
biochemical tests on the samples. Most clinical diagnostic applications have focused on the 
detection of biomolecules as early indicators of diseases but can also include monitoring of 
regular metabolic parameters such as glucose and lactate [36]. These tests require specific 
analytical techniques, as well as skilled personnel to collect the desired samples from the patient 
and perform the tests. 
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1.6 Pathogens and Biomolecules  
Biosensors can detect pathogens such as bacteria, viruses or a range of biomolecules such as 
proteins, enzymes, DNA and RNA for clinical diagnostics. Foodborne illnesses can be caused by 
pathogens such as bacteria, viruses, parasites, toxins and prions [32]. The four major foodborne 
bacteria are Salmonella, Listeria monocytogenes, Campylobacter and Escherichia coli (E. coli) 
O157:H7. Viral infections can present generic symptoms and can be difficult to diagnose. A 
biosensor would allow a physician to determine the specific virus quickly and prescribe 
appropriate treatment. Viruses are capable of spreading rapidly by natural means and their ability 
to mutate quickly makes their detection a challenging task. In recent times, the emergence of 
avian influenza (AI) with pandemic potential has made the rapid screening of AI virus strains 
crucial in controlling worldwide outbreaks. Some of the other viruses of interest include dengue 
virus [37] rabies virus [38], human immunodeficiency virus (HIV) [39] and Adenovirus [40]. 
The rapid and quantitative detection of biomolecules such as protein biomarkers and nucleic 
acids is important for both clinical diagnostics and drug discovery applications. Early detection is 
particularly important in cases such as cancer, because the detection of the early stages of a 
disease can enable a greater probability of a successful treatment. 
1.6.1 Bacteria and Viruses 
Among the various types of bacteria, the most economically significant [41] infections are 
caused by E. coli O157:H7.  Although most strains are harmless and some even live in the 
intestines of healthy humans and animals, the O157:H7 strain produces a potent toxin and can 
cause severe illness. Typical symptoms include abdominal cramping, diarrhea and bloody stools. 
Occasionally this infection results in kidney failure. There have been many instances of meat 
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recalls in the past. For example, in 2003, Howard Beef Processors in Minnesota voluntarily 
recalled approximately 194,700 pounds of frozen ground beef products. Recalls of this kind can 
be avoided if the bacteria are detected in advance before the meat reaches the market.  
Among the various types of viruses, avian influenza (AI) virus has raised concerns about a 
potential pandemic. AI viruses are classified into sub-types based on antigenic differences of the 
surface glycoproteins, namely Hemagglutinin (HA) and neuraminidase (NA). To date, sixteen 
HA (H1 through H16) and nine NA (N1 through N9) subtypes have been identified [42].  AI 
viruses are usually found in wild birds but can also infect people, pigs, horses and other animals. 
In Asia and Europe [43], numerous outbreaks of AI virus have been reported in recent years. The 
economic significance of AI is substantial. According to CDC [44], the direct economic loss 
could be up to hundreds of billion dollars. 
1.6.2 Insulin  
Insulin is a hormone responsible for glucose metabolism. Insulin is produced in the pancreas 
within the β-cells of the islets of Langerhans. Diabetes mellitus (DM) is a disease where the 
patient has difficulties in maintaining normal blood glucose levels. DM is mainly caused when 
insufficient insulin is produced by the β-cells in the pancreas, or the patient’s body is unable to 
effectively utilize the insulin produced. The presence of high blood glucose levels in a patient 
can induce secondary complications such as nephropathy and retinopathy. The presence of low 
blood glucose levels is known as hypoglycemia which can lead to insulin shock as well as death. 
There are three main types of DM, namely, type I (insulin dependent), type II (non-insulin 
dependent) and Gestational DM [45]. Type I DM is caused by an auto-immune reaction where 
the body’s defense system attacks the insulin-producing cells. Patients with type 1 DM produce 
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very little or no insulin. Type I DM can affect people of any age, but mostly occurs in children or 
young adults. Type II DM accounts for at least 90% of all cases of diabetes and is characterized 
by insulin resistance and relative insulin deficiency. The occurrence of type II DM is typically 
seen in patients over the age of 40 but can occur earlier, especially in populations with high 
diabetes prevalence [45]. Gestational DM is a type of diabetes that causes high blood glucose 
levels in a patient during pregnancy. It develops in one in 25 pregnancies worldwide [45]. 
Gestational DM usually disappears after pregnancy, but patients and their offspring are at an 
increased risk of developing type II DM later in life. Diabetes is a chronic disease and has 
reached epidemic proportions in recent years. The prevalence of diabetes for all age groups 
worldwide by the year 2030 has been estimated to be 7.8% by the International Diabetes 
Federation [46].  The total number of people with diabetes is projected to rise from 171 million 
in 2000 to 439 million by 2030 [46]. 
Insulin monitoring is very important for clinical diagnosis of DM and several analytical methods 
have been devised for insulin detection. Some of these analytical methods reported include 
immunoaffinity chromatography with subsequent liquid chromatography/mass spectrometry 
analysis [47] immunoassays [48], imaging ellipsometry [49], electrochemical [50], amperometric 
[51], surface plasmon resonance [52] and mass-sensitive biosensors [53]. The efficiency of 
biochemical tests for disease diagnosis is determined by its sensitivity, specificity and time taken 
for obtaining the test results. There is a large demand for the development of inexpensive and 
easy to perform clinical diagnostic methods, which can provide fast and reliable measurements 
of the metabolic parameters of a human body with minimum invasion. 
Type II DM has been observed [54] to be a progressive disease with the reduction in the 
pancreatic β-cell function commencing 10-12 years before diagnosis. By the time most patients 
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are diagnosed with type II DM, their pancreatic β-cell function may have deteriorated up to 50%. 
The reduction in β-cell function can lead to insulin deficiency and monitoring the insulin level 
can be highly useful to predict the occurrence of type II DM in a patient.  The current methods 
for insulin detection are based on large automated immunoassay analyzers. These large analyzers 
are expensive and are not suitable for point-of-care-testing in a physician’s office.  
1.7 Conventional Biodetection Methods 
The conventional biosensing techniques are listed in Figure 1.3. Morphological methods are 
performed by using microscopic techniques such as bright field, scanning electron microscopy 
(SEM) and atomic force microscopy (AFM). Morphological methods are more suitable for 
qualitative analysis than quantitative analysis. The sample preparation steps can be time 
consuming and in some cases, the sample preparation method can alter the morphology of the 
sample being investigated.                                                       
               
Figure 1.3 Conventional biodetection methods 
Culturing and colony counting (CCC) method is performed by growing and multiplying the 
pathogens in a culture media such as agar under controlled laboratory conditions. CCC methods 
used for bacterial detection are cumbersome and time consuming, typically require weeks to 















and subsequent biochemical and serological confirmation [55]. Immunology based method 
involve antigen-antibody reactions. Examples of immunology based methods include enzyme 
immunoassay (EIA) [56], enzyme linked immunosorbent assay (ELISA) [57], enzyme-linked 
immunomagnetic chemiluminescence (ELIMCL) [58], immunomagnetic separation [59], 
immune-precipitation assay [60] and western blot test [61]. Some of the problems associated 
with immunology based methods are low sensitivity of the assays, low affinity of the antibody to 
the analyte/pathogen being measured, and potential interference from contaminants [62]. 
Polymerase Chain Reaction (PCR) is a nucleic acid amplification technology that was developed 
in the mid-80s [63]. It is based on the isolation, amplification and quantification of a short DNA 
sequence including the targeted pathogen’s genetic material. A target DNA can be amplified 1-
million-folds in less than an hour, with sensitivities in theory down to a single target pathogen 
[64] and is therefore a widely used detection method for pathogens in food.  The PCR method is 
less time-consuming than techniques such as like culturing and plating. PCR can take anywhere 
from 5 to 24 h to produce a detection result depending on the type of PCR variation used and this 
time frame does not include any previous enrichment steps. A false negative PCR test result can 
occur due to interference with target-cell lysis necessary for nucleic acid extraction, nucleic acid 
degradation and/or direct inhibition of the PCR.  The disadvantage of PCR based methods is that 
it is expensive, complicated and required highly skilled workers to carry out the tests. 
1.7.1 Limitations of Conventional Biodetection Methods 
In order to prevent the spreading of diseases, prevent a pandemic and obtain important 
epidemiological information about any pathogen outbreaks, the industry needs a reliable, 
specific, sensitive, and rapid method for biodetection. The earlier the pathogen outbreak is 
detected the easier it is to prevent a pandemic by adopting appropriate confinement strategies. 
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The earlier the symptoms of a disease such as cancer/ diabetes are detected through clinical 
diagnostics, the better are the chances of a successful treatment. Most of the conventional 
methods are effective but are time consuming and required highly skilled professional to perform 
them. Also, the test sample needs to be transported to dedicated laboratories where these tests are 
performed. There is a need for a technology that can enable rapid, reliable, simple and sensitive 
detection. In addition, it should be capable of in-situ real-time monitoring at a low cost. In recent 
years, there has been much research activity in the area of biosensor development for detecting 
pathogens and physiologically relevant biomolecules. Biosensors are expected to address the 
limitations of traditional methods by enabling much faster detection schemes.  
1.8 Biosensor 
A biosensor is a sensing device comprising of a bio-recognition element and a transducer. A bio-
recognition element specifically identifies and interacts with an analyte and the changes in its 
physicochemical properties (optical, thermal, electrical and thermodynamic properties) are 
usually converted into an electrical signal by a transducer. Figure 1.4 shows the schematic of a 
biosensor. The bio-recognition element is a sensing material and may include enzyme, 
antibodies, microorganism, tissues, organelles and DNA/RNA [65]. The biosensors can be 
classified based on the type of bio-recognition element or the transducing method used. Based on 
the bio-recognition element, the biosensors can be classified as enzyme sensors, immunosensors, 
nucleic acid probe sensors, cell-, tissue- and organelle based sensor. Based on the transducing 
method, biosensors can be classified as piezoelectric biosensor, optical biosensor and 




Figure 1.4 Schematic of a biosensor 
1.8.1 Bio-Recognition Element 
Antibody based sensors, also known as immunosensors, are based on the specificity of antibody-
antigen reaction to produce a change in the transducer signal. Both polycolonal and monoclonal 
antibodies can be used and the suitability depends mainly on their specificity.  Antibodies can be 
directly immobilized on the surface of the transducer by covalent bonding through amino, 
carboxyl or aldehyde groups. Antibodies can also be attached to the surface of magnetic beads to 
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perform immunomagnetic separation and detection. Antibody based biosensors with various 
transducing methods have been previously reported. For example, immunosensors have been 
designed for monitoring cancer cells [66], for cancer marker cell detection [67], for bacteria and 
virus determination assays [68], for toxins [69], etc. Enzyme based biosensors are based on using 
enzymes which are specific to the biomolecules under detection to catalyze the generation of a 
product which can be quantified by a transducer. Most of the enzymes used in biosensors are 
oxidases that react with dissolved oxygen to produce hydrogen peroxide. For example, 
oxidoreductase enzymes have been used for the detection of lactate [70], alcohol [71], 
cholesterol [72], etc. Nucleic acid based biosensors integrate a natural and biomimetic form of 
oligo- and polynucleotides and rely on the very strong base pair affinity between complementary 
sections of nucleotide strands for their high sensitivity and selectivity. In recent years, the use of 
synthetic oligodeoxyribonucleotides (ODNs) is gaining popularity. End-labels, such as thiols, 
disulfides, amines, or biotin, are incorporated to immobilize ODNs to the surface of a transducer 
element. Electrochemical DNA biosensors where the base-pair recognition event is converted 
into a measurable electrical signal are being used for the diagnosis of genetic diseases, 
pathogens, biomolecules of clinical interest, etc. [73] reported a low-density electrical 16S rRNA 
specific oligonucleotide microarray for detecting pathogens such as E. coli, Pseudomonas 
aeruginosa, Enterococcus faecalis, Staphylococcus aureus, and Staphylococcus epidermidis. 
1.8.2 Transducer element 
Optical biosensors include surface plasma resonance (SPR) biosensor, adsorption and reflection 
biosensor, luminescence biosensor, fluorescence biosensor and optical fiber biosensor. SPR and 
fluorescence biosensors are the most popular optical biosensors. Fluorescence biosensors use 
fluorescent labels for signal generation and the intensity of the fluorescent signal is used to 
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determine the amount of the antigen being detected [74].  SPR is a direct optical-sensing 
technique that measures the refractive index change due to bio-specific interactions occurring in 
the vicinity of a thin metal film surface [75]. SPR biosensors for detecting influenza virus [76] 
and plant virus [77] have been reported. Piezoelectric biosensors consist of mass-sensitive 
piezoelectric crystals with excitation electrodes. The piezoelectric transducers allow a binding 
event to be converted into a measurable signal, such as resonant frequency changes [78]. The 
most popular transducer design is based on the quartz crystal microbalance (QCM), adapted to 
the liquid medium, which gives a direct response signal to characterize the binding event 
between a sensitive layer grafted onto the surface transducer and the analyte to be detected [78]. 
QCM has been used for the detection of DNA, protein–ligand interactions, virus capsids, 
bacteria, and mammalian cells [79]. A microcantilever is another type of mass-sensitive 
biosensor. The principle of this detection is based on the change in the mechanical response of a 
cantilever due to molecular adsorption on the functionalized cantilever surface. The sensitivity of 
a microcantilever is high enough to detect a single virus particle [80]. Electrochemical biosensors 
can be classified into amperometric, potentiometric and impedance biosensors based on the 
electrical parameters they measure. Potentiometric biosensors use ion-selective electrodes (ISE) 
and ISFET to measure the change in electric potential due to the accumulation of ions resulting 
from an enzyme reaction [81]. Amperometric biosensors measure the change in electrical current 
(typically in the nA to µA range) due to the oxidation/reduction process of an electroactive 
species. The working electrodes are usually a noble metal or a screen-printed layer covered by a 
bio-recognition element [82]. The amperometric biosensors are often used for analytes such as 
glucose, lactate [83], and sialic acid [84]. In addition, the detection of biological agents such as 
Bacillus cereus and Mycobacterium smegmatis [85], the serological diagnosis of 
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Francisellatularensis [86], pesticides and nerve agents [87] have been reported. Potentiometric 
biosensors measure the potential difference generated across an ion-selective membrane 
separating two solutions at virtually zero current flow. A potentiometric sensor array [88] for 
investigating the cytotoxicity of hydroquinone to cultured mammalian V79 cells has been 
reported. Impedance biosensors are based on the combined measurement of the resistive and 
capacitive properties of the targets in response to a small amplitude sinusoidal excitation signal 
[89-90]. Impedance detection involves measuring the change in impedance caused by the 
binding of analytes to receptors (antibodies, DNA, proteins etc.) immobilized on the surface of 
electrodes [91-93], change in the conductivity of the medium caused by the growth of bacteria 
[94-96], bacterial cells captured on an electrode surface using Dielectrophoresis [97-100], and 
change in the ionic concentration of a medium caused by activity of enzyme used as labels [101-
104]. Calorimetric biosensors are based on measuring the heat of a biochemical reaction at the 
sensing element. These biosensors consist of temperature sensors with immobilized 
biomolecules. Once the analyte comes into contact with the biomolecules, the reaction 
temperature is measured. The total heat produced or absorbed is proportional to the molar 
enthalpy and the total number of molecules in the reaction. The change in temperature is 
proportional to the analyte concentration. Calorimetric biosensors have been used for food, 
cosmetics, pharmaceutical and other analysis. For example, a microcalorimetric sensor has been 
used for L-malic acid determination [105] in various types of food. 
1.9 Immunoassay 
Immunoassay is a technique that exploits the sensitivity and specificity of antibody-antigen 
interactions for the detection of relevant analytes [106]. Immunoassays are routinely used for the 
quantification of proteins and small molecules in medical diagnostics, proteomics, 
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pharmaceutical and biological research [106]. Immunoassays can be broadly classified into 
homogenous and heterogenous immunoassay. In homogenous immunoassays, antibodies and 
antigens interact within a solution. In heterogeneous immunoassays, antibodies are immobilized 
on a solid support and interact with the antigen at the boundary layer. For example, the 
antibodies can be immobilized on the surface of micro and nano beads. The micro and nano 
beads can be either paramagnetic or non-magnetic.  
1.9.1 Pretreatment of Biological Samples 
A sample pretreatment and enrichment step is necessary for detecting biological samples at very 
low concentrations. A generic analytical procedure [107] can be broken down into three broad 
categories as shown in Figure 1.5: the analytical principle on which the measurement is based, 
the analytical method which is the concept for optimizing the conditions of the analytical 
principle chosen, and the analytical procedure which includes all considerations from the analyte 
to the analytical result. It is necessary to pretreat raw biological samples (from body, laboratory 
or field) to ensure that the analyte to be detected is present in a form compatible with the 
measurement process and also be free of any foreign substance that may interfere with the 
accuracy of measurement. In a traditional sample pretreatment process, several steps that require 








Figure 1.5 Schematic of a general analytical process 
1.9.2 Micro/Nano Magnetic Bead Immunoassay 
Microbeads are widely used due to their high surface area to volume ratio and ability to function 
as a simple mechanism of delivering antibodies to desirable locations within the microfluidic 
device [108]. Microbeads can be either magnetic or non-magnetic. For non-magnetic beads, they 
can be physically retained by dam-like microstructures [109] to facilitate the removal of unbound 
analytes.  Alternatively, this can be achieved through the use of dielectrophoresis [110] or 
electrostatic forces [111]. The use of magnetic beads eliminates the need for retention 
microstructures. In magnetic bead based immunoassays, antibody coated magnetic beads can be 
immobilized on the device surface [112] or on the sensor surface [113].  The manipulations of 
magnetic beads can be accomplished in two ways: (1) by placing a permanent or electro magnet 
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outside the device, and (2) by fabricating the magnet inside the device.  Approach (1) has the 
advantage of ease of fabrication and low cost. Approach (2) allows a more precise control of the 
field strength and direct contact with the magnetic beads.  
1.9.3 Immunomagnetic Separation 
In recent years, the use of micro or nano superparamagnetic (SPM) beads in immunological 
assays has increased as the magnetic properties are shown to improve the assay sensitivity and 
duration [114]. In a magnetic immunoassay, the SPM beads are coupled with the target analyte 
using various immobilization techniques. One of these techniques is the antibody-antigen 
complex. The various steps of an immunomagnetic separation technique are illustrated in Figure 
1.6. In this process, the SPM beads are first activated with functional groups that can bind to an 
antibody (Ab) specific to the target analyte. Upon mixing with the test sample containing the 
analyte, the Ab-SPM beads complex selectively capture the target analyte. The use of Ab-SPM 
complex provides a more efficient interaction between the capture Ab and the target analyte, 
when compared to Ab immobilized on the bottom of a microwell. The Ab-SPM particle complex 
with captured target is then magnetically separated by subjecting the test sample to a magnetic 























Figure 1.6 Basic steps of immunomagnetic separation (a) Introduction of the beads and the 
analyte mixture, (b) mixing and binding of the target analyte to Ab-SPM complex (c) magnetic 
separation of the Ab-SPM complex and target analyte conjugate, (d) washing of the non-target 
entities and background fluid by buffer 
 
 
1.10 Micro Total Analysis System  
In 1990, a new paradigm of integrated microfluidic devices, the concept of miniaturized total 
chemical analysis system (TAS) or µTAS was proposed by [115] in which silicon chip analyzers 
incorporating sample pretreatment, separation and detection were the key features. Figure 1.7 
lists the various components of a µTAS which can be integrated on a single system to automate 
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sample injection, fluid and particle handling, reactors and mixing, separation and detection [116].  
A fully integrated microfluidic system can be designed to perform all the standard operations of 
a µTAS. For example, a cell sample pretreatment step can be performed by micromixing the 
cells with fluorescent dyes. These fluorescent labeled cells can then be sorted and transported to 
subsequent components for further post-processing steps such as sorting and optical detection. 
All the operations of a µTAS are analogous to those performed in a conventional laboratory 
using the traditional equipment. A µTAS has the potential to replace the traditional, complicated 
biodetection systems and save time and labor. 
                      
Figure 1.7 Components of a µTAS 
 
The following sections provide a brief description of the various components of a µTAS. 
1.10.1  Microchannels 
Microchannels and reservoirs are passive components used to transport and confine microscale 
fluids. Microchannels can be defined as channels whose dimensions are less than 1 mm and 
greater than 1 μm. Currently, most microchannels fall into the range of 10 to 100 μm. 
Microchannels can be fabricated on a wide variety of substrate materials such as glass, polymers 
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and silicon. The choice of the material and fabrication methods depend on various factors like 
device yield, processing cost, the compatibility between the channel material and  the fluid to be 
transported (hydrophobic, hydrophilic, chemical resistance, biocompatibility), geometry 
constraints like depth, width, surface roughness of the channel surface, and optical transparency 
requirements.  
1.10.2  Micropump 
A micropump is an essential component of a μTAS and delivers fluid between different 
components in a controlled manner. Micropumps can be classified into two main categories: 
mechanical micropumps and non-mechanical micropumps. Mechanical micropumps can be 
further classified into two categories: dynamic pumps and displacement pumps [117]. Dynamic 
pumps add energy to the working fluid directly to increase its momentum. A few dynamic 
pumps, mostly micro gear pumps, have been reported. For example, a gear micropump 
fabricated by LIGA [118] and driven by a small electromagnetic motor, has two opposing in-line 
gears (0.6 mm in diameter) and can provide a maximum flow rate of 180 μL/min and a 
maximum pressure of 100 kPa while operating at 2250 rpm. Dynamic pumps have moving parts 
and have complicated fabrication process. Dynamic pumps with moving parts such as micro 
gears can cause damage to bio-samples and are not suitable for biological applications. 
Displacement pumps operate by exerting pressure on the working fluid through one or more 
moving boundaries. The majority of micropumps are displacement pumps in which the moving 
surface is an oscillating diaphragm and also known as diaphragm pumps.  Common pump 
diaphragm materials reported include silicon [119], glass [120], silicone rubber [121], polyimide 
[122], and PDMS [123]. Different actuating mechanisms have been used to drive the diaphragm 
including piezoelectric [124], electrostatic [125], thermo-pneumatic [126], pneumatic [127] and 
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electromagnetic [128]. Flow rates ranging from as low as 0.0006 mL/min [129] to as high as 16 
mL/min [130] have been reported with diaphragm pumps. Non-mechanical micropumps convert 
non-mechanical energy (electrical/magnetic) to kinetic energy to add momentum to the working 
fluid. Non-mechanical micropumps include electrohydrodynamic (EHD pumps, electroosmotic 
(EO) pumps, and magnetohydrodynamic (MHD) pumps. EHD pumps [131-133] utilize 
electrostatic forces acting on dielectric liquids to generate flow. One of the fundamental 
requirements of EHD pumps is that the fluid must have low electrical conductivity. EO 
micropumps [134-136] are based on liquid flow generated by the presence of an electric field 
when an ionic solution is in contact with a charged solid surface. EO pumps have the limitations 
of high voltage requirement and electrically conductive fluid. MHD pumps are based on Lorentz 
force as the driving force with interaction of electrically conductive fluids and magnetic field. 
MHD pumps require working fluids with higher conductivity (greater than 1 S/m) and bubble 
generation due to ionization is a major drawback.  
Micropumps used in μTAS for biomedical applications have requirements such as: 
biocompatibility, controllable flow rates, smaller footprints and less power consumptions. In 
general, non-mechanical pumps when compared to mechanical pumps have higher power 
requirements and limit the electrical properties of the working fluid. Polymer materials such as 
PDMS and PMMA are being widely used these days due to their biocompatibility and ease of 
fabrication of multilayer monolithic devices. In pneumatically driven diaphragm micropumps, 
the choice of the diaphragm material is important and a low-modulus diaphragm material is 
widely used to achieve maximum diaphragm deflection for a given driving force. It is also an 
advantage to select a diaphragm material such as PDMS that can be readily integrated into an 
existing device without affecting the fabrication process. A displacement pump with PDMS as 
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the structural material, based on moving membranes actuated in a sequence by external 
pneumatic pressure, can meet most of the requirements of a micropump used in μTAS for 
biomedical applications. 
1.10.3 Micromixer 
Micromixer is another important component of a μTAS which often require the mixing of 
reactants. Mixing at the micro scale is a challenging task because the flow is laminar and mixing 
is dependent on molecular diffusion. Micromixers can be classified into passive and active 
devices. Passive micromixers have no moving parts, do not require external energy source and 
achieve mixing through the topology of the microfluidic device. Different types of passive 
micromixers have been reported: T-mixers [137], Y-mixer [138], injection micromixer [139], 
chaotic advection micromixers with obstacles in the fluid path [140], droplet micromixer [141].  
Active mixers usually have moving parts and use external energy source to disturb the flow for 
mixing. Active micromixers are classified based on the type of external disturbance used. 
Examples of active micromixers include T-mixer with pressure disturbance [142], micromixer 
with EHD disturbance [150], micromixer with DEP disturbance [151], micromixer with MHD 
disturbance [145], micromixer with EK disturbance [146], and micromixer with acoustic 
disturbance [147]. In general, active mixers have higher mixing efficiency [148]. Some of the 
factors to be considered in selection of the type of micromixer used in a μTAS include the ease 
of integration with other components, fabrication material used and compatibility of actuation 
mechanism with the overall design of the μTAS. For example, if the fabrication material and 
actuation mechanism used for the micromixer and the micropump used in μTAS are the same, 




The separation of the target biomolecules from a test sample is an important part of the 
biochemical analysis. One of the methods for isolating biomolecules of interest from the bulk 
sample is by attaching them to functionalized microbeads through a mixing process, followed by 
separation of the microbeads. In recent years, various separation techniques have been reported 
and most of these involve continuous flow separation where the sample solution is continuously 
introduced through a separator device. There are various separation techniques that can be used 
for separation of the particles of interest from the test sample. Pinched flow fractionation [149] 
and hydrodynamic filtration [150] permit size based sorting of micrometer sized particles. 
Filtration obstacle separator [151] is based on flow through an array of pillars where the spacing 
between pillars is designed to function as an obstacle to particles in the sample. Lateral 
displacement separation [152] is based on pressure gradient from slanted obstacles designed to 
perform a size based separation of microparticles, DEP [153] is a separation technique where 
non uniform electric field can be used for separation based on the size and polarisibility of 
microparticles. In recent times, the use of magnetic micro and nanobeads for immunomagnetic 
separation has gained popularity. The use of magnetic microbeads allows for magnetic 
separation. The magnets used can be external or integrated within the device. The advantage of 
an integrated magnet is that the magnetic field strength requirement is low due to the close 
proximity of the magnetic beads to the microfabricated magnet. Several integrated 
electromagnets such as the meandering permalloy-core, copper-wire design [154], the spiral 
design [155] and the serpentine copper-wires with a semi-encapsulated permalloy [156] have all 
been explored. However, the process of integrating microfabricated magnets with a microfluidic 
device takes many complicated fabrication steps, which make the approach costly. External 
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permanent magnets used for magnetic bead based immunoassay are usually Neodymium Iron 
Boron (NdFeB) magnets with a magnetic flux density up to 500 mT at the pole surface [157].  
External electromagnets have the advantage of switching on and off and their field strength can 
be varied. However, electromagnets have not been as popular as permanent magnets because 
even with a large number of windings and high currents, it is difficult to build a small 
electromagnet with field strength comparable to a small NdFeB magnet. Also, electromagnets 
also have a joule heating problem. 
1.10.5 Microsensor 
The different types of biosensors based on the bio-recognition element and the transducer 
element are discussed in the previous section. The biosensors can also be broadly classified into 
label-free and labeled biosensors. In case of the labeled biosensors, labels such as fluorescent 
tags, luminescent compounds or radioisotope labels are attached to the target molecule to 
enhance signal generation and visualization. The labeling methods are time consuming and 
complicated and can substantially increase the assay complexity. Additionally, the attachment of 
labels can interfere with the molecular reaction and labeled biosensors cannot be used for real 
time measurements. A label-free biosensor on the other hand can be used for direct real time 
detection involves lesser assay complexity and is noninvasive in nature. Label free assays are 
faster than the labeled ones because they do not need additional incubation time and activation 
step for the attachment of labels. Several biosensors such as SPR, QCM, impedance biosensor, 
fiber optic immunoassay and magnetoelastic-immunosensors have been developed. Among the 
label-free biosensors, the impedance biosensors have added advantages due to their simplicity of 
operation and the speed of assay. Also, impedance biosensors have no moving parts and are 
easier to fabricate and integrate within a point-of-care testing device. 
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1.11 Primary Objectives of Study 
The primary goal of the study is the development of a PDMS based µTAS for rapid, multi-
purpose, impedance based detection of biomolecules.  The following objectives have been 
established to attain the primary goal. 
1. Design, fabrication and testing of pneumatically actuated PDMS based micropumps 
2. Design, fabrication and testing of pneumatically actuated PDMS based active 
micromixers 
3. Integration of micropump and micromixer with interdigitated electrodes (IDE) for 
impedance measurements 
4. Numerical simulation of microfluidic components using COMSOL MultiphysicsTM 
5. Development of magnetic microbead separation scheme 
6. Application of integrated microfluidic system towards biotin conjugated fluorescent 
(BCF) microbead detection based on streptavidin-biotin conjugation reaction. 
7. Application of  integrated microfluidic system towards immuno microbead based insulin 
detection 
1.11.1 Specific Tasks 
The individual tasks associated with the primary areas described previously are listed below. 
i. Design, fabrication and testing of  pneumatically actuated PDMS based micropumps 
1. Mask design and fabrication of SU-8 mold 
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2. PDMS casting and oxygen plasma bonding followed by packaging 
3. Flow characterization of three different designs of micropump 
ii. Design, fabrication and testing of  pneumatically actuated PDMS based active 
micromixers 
1. Mask design and fabrication of SU-8 mold 
2. PDMS casting and oxygen plasma bonding followed by packaging  
3. Mixing efficiency characterization of  three different designs of micromixer 
iii. Integration of micropump and micromixer with IDE for impedance measurements 
1. Mask design for integrated device and SU-8 mold fabrication 
2. PDMS casting and oxygen plasma bonding followed by packaging 
3. Flow characterization of micropump 
4.  Mixing efficiency characterization of the micromixer 
iv. Development of magnetic microbead separation scheme 
1. Selection of permanent magnet and configuration to optimize microbead separation 
2. Separation efficiency at different sample flow rates 
v. Application of  integrated microfluidic system towards immuno microbead based insulin 
detection 
1. Mask design for integrated microfluidic system and SU-8 mold fabrication 
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2. PDMS casting and oxygen plasma bonding followed by packaging 
3. Testing integrated microfluidic system for detecting BCF microbeads and insulin 
1.12 Dissertation Organization 
The remainder of this dissertation is divided into six chapters: Chapter 2: Theory and Design, 
Chapter 3: Microfabrication, Chapter 4: Experimental Setup and Testing, Chapter 5: Results and 
Discussions, Chapter 6: Conclusions and Chapter 7: Future Work. A bibliography of references 
is provided at the end of the dissertation. The second chapter provides details of the theory of 
operation, mask design and dimensions of the various devices fabricated. The third chapter 
describes the microfabrication procedure for all the components of the microfluidic system. The 
fourth chapter discusses all the experimental setup and testing protocols used in this study. The 
fifth chapter presents and discusses the results of the various experiments and simulations. The 
sixth and the seventh chapters summarize the accomplishments of this study and identify the 


















2. THEORY AND DESIGN 
The following sections describe the theory and design of the microfluidic system components 
used in the present study. The focus will be on the design of the various components of the 
integrated microfluidic system such as micropump, micromixer, microbead magnetic separation 
scheme and impedance sensor. 
2.1 Micropump 
2.1.1 Working Principle 
The micropump consists of two PDMS layers bonded together by oxygen plasma bonding. One 
of the layers, referred to as the control layer, contains a sequence of air chambers that are 
connected via microchannels. The first air chamber has a smaller volume compared to the rest. 
The bottom surface of these air chambers is thin and functions as membranes that deflect when 
the air chambers are filled with compressed air. The second PDMS layer, referred to as the 
fluidic layer has a microchannel through which the fluid is pumped. An external mini air 
compressor is used to produce compressed air supply for the micropump. The pneumatic 
actuation frequency is controlled via a 3-port ultra-miniature solenoid valve. When a voltage is 
applied across the solenoid, the solenoid connects the micropump’s actuator layer inlet to the 
compressed air supply. When compressed air is introduced into the air chamber inlet via a 
solenoid valve, air fills the three air chambers in a sequence, starting with the smallest chamber. 
The membrane of the smallest chamber deflects first and functions as an active valve to 
minimize back flow. There is a time delay between the filling of different air chambers due to the 
difference in chamber volume and also the presence of the interconnecting microchannels. The 
deflection of the membranes in a sequence leads to a peristaltic actuation and causes the fluid in 
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the underlying fluidic layer to be squeezed in one direction as shown in the Figure 2.1. When the 
solenoid valve is turned off the compressed air is released through the same path it enters the air 
chamber and the air chambers are depressurized causing the membrane to move back to its initial 
position with zero deflection. 
2.1.2 Micropump Geometry 
Figure 2.2 shows the various layers of the micropump assembly. Both the PDMS layers have a 
glass layer for mechanical support with access holes for inlet and outlet. Three different 
micropump design geometries were developed and evaluated in the present study. The three 
designs differ in the geometry of the air chambers and the length of the interconnecting 
microchannels. The AutoCAD diagrams of the three micropump designs, namely Design1, 
Design2 and Design3 are as shown in Figures 2.3, 2.4 and 2.5 respectively. The fluidic layer 
microchannel design was the same for all three pumps. Figure 2.6 shows the design of the fluidic 
layer microchannel. The design of the air chambers of the control layer is a significant design 
parameter, since it governs the dynamic response of the micropump such as the peak operating 
frequency and the volume displaced per stroke. In general, large air chambers displace large fluid 
volume per stroke and thus lead to a large flow rate. Also, large air chambers require long fill 
and evacuate time, thus affecting the peak operating frequency of the micropump. The 
interconnecting microchannels between the air chambers provide a time delay between the 
sequential actuation of each membrane. This cycle of pressurizing and depressurizing of the air 






Figure 2.1 Cross-sectional view of the actuation mechanism of the pump. (1) Liquid enters the 
microchannel (2) When compressed air fills the air chambers, the first membrane deflects 
downwards (3) – (5) sequential actuation of PDMS membranes causing the liquid to be pumped 
to the right. 
  



















R1 3.0 L1 5.8 
R2 0.84 L2 1.98 
R3 2.41 L3 4.75 
R4 1.68 L4 4.82 
R5 2.16 L5 0.61 
R6 2.54 L6 0.5 
R7 2.27 L7 1.98 





R1 1.5 L5 1.86 
R2 0.25 L6 2.18 
R3 0.53 L7 1.1 
L1 7.77 L8 1.8 
L2 0.62 L9 0.77 
L3 0.78 L10 0.79 





Figure 2.5 Micropump Design3 – Control Layer 
 
 
Figure 2.6 Fluidic layer microchannel design 
2.2 Micromixer 
2.2.1 Working Principle 
The micromixers used in this study utilize oscillating membranes to achieve active mixing. The 
micromixer consists of two PDMS layers bonded together by oxygen plasma bonding. One of 
the layers, referred to as the control layer, has air chambers. The bottom surface of the air 




















compressed air. An external mini air compressor is used to produce compressed air supply for 
the micromixer. The pneumatic actuation frequency is controlled via a 3-port ultra-miniature 
solenoid valve. When a voltage is applied across the solenoid, the solenoid connects the 
micromixer’s actuator layer inlet to the compressed air supply, causing the membranes to deflect. 
The second PDMS layer, referred to as the fluidic layer, has a mixing chamber with two inlets 
and one outlet. The two PDMS layers are bonded together by oxygen plasma bonding, with the 
mixing chamber in alignment with the air chambers. A set of glass layers with access holes to the 
inlet and outlets of the PDMS layers provide mechanical support. Figure 2.7 illustrates the 
motion of the micromixer membrane during one actuation cycle.  
 
Figure 2.7 Working of a micromixer with two pneumatically actuated membranes 
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These PDMS membranes can be moved up and down sequentially and the membrane deflection 
generates fluid convection in the mixing chamber. This agitates the mixing species leading to 
better mixing. When the solenoid valve is turned off the compressed air is released through the 
same path it enters the air chamber and the air chambers are depressurized causing the membrane 
to move back to its initial position with zero deflection. 
 







2.2.2 Micromixer Geometry 
In the present study, three different micromixer design geometries were developed and 
evaluated. The primary difference between these designs is the membrane configuration in the 
control layer and the interconnecting delay microchannels. Design1, as shown in Figure 2.9, uses 
two independently operated semi-circular membranes to achieve mixing. Design2, as shown in 
Fig. 2.10, utilizes four separate quadrant membranes which can be independently controlled. 
Design3, as shown in Figures 2.11a and 2.11b, uses 6 membranes that can deflect in a sequence. 
In Design3, unlike Designs 1 and 2, the air chambers are interconnected in series by 
microchannels (100 µm x 100 µm). The first air chamber in the series is connected to the 
compressed air source and the interconnecting microchannels provide the delay between the 
sequential actuation of each membrane. The fluidic channel layer for all the micromixers is the 
same and consists of a circular mixing chamber with two inlets and one outlet. Figure 2.12 shows 
the design geometry of the fluidic layer of the mixer. 
                                                   
  














     
             




          
       (a)           (b) 
Figure 2.11 (a) Micromixer Design3 control layer with six air chambers connected in series (b) 


























Figure 2.12 Fluidic layer of the micromixer with a mixing chamber 
2.3 Integration of Micropump and Micromixer 
The individual micropumps and micromixers were tested for their performance. Among the 
micropump and micromixer designs, Design3 of the micropump and Design3 of the micromixer 
were selected for integration into a single microfluidic system. The performance and selection 
criteria for the micropump and micromixer will be discussed in Chapter 5 (Results and 
Discussions). The control layers of selected micropump and micromixer designs were combined 
into a single PDMS control layer to achieve an integrated micromixer-micropump system. Figure 
2.13 shows the various layers of the fully integrated micromixer-micropump system. The design 
of the fluidic layer for the integrated micromixer-micropump system is shown in Figure 2.14. 
Figure 2.15 shows the alignment of the control layer on top of the fluidic layer of the integrated 
micromixer-micropump system. The important alignment requirements are to center the 
micromixer air chambers with the mixing chamber below and position the micropump air 















Figure 2.13 Different layers of the integrated micromixer-micropump assembly 
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Figure 2.15 Alignment of the layers of integrated micromixer-micropump 
2.4 Impedance Spectroscopy (IS) 
The electrical impedance Z of a system can be determined by applying a small amplitude voltage 
perturbation to the system and then measuring the current response. Z is the ratio of the voltage -





      




                                                                                                        (2.1) 
where Vo and Io are the peak voltage and current, f is the frequency, t is the time, Φ is the phase 
shift between the voltage-time and current-time functions, and Y is the complex conductance or 
admittance. Z is a complex function and can be described by the modulus |Z| and the phase shift 
Φ or by the real part ZR and the imaginary part ZI, as illustrated in Figure 2.16 The impedance 
data can be plotted in two different ways: the Bode plot which plots log |Z| as a function of log f, 
or the Nyquist plot which plots ZR versus ZI. The name IS refers to the fact that impedance 
generally varies with frequency. The impedance spectrum is often analyzed using the theory of 
equivalent circuit, which uses circuit elements such as resistances and capacitances to represent 
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the various physicochemical properties of the system under study [158]. The experimental data is 
curve-fitted by the equivalent circuit model using non-linear least square fitting techniques. 
                              
 
Figure 2.16 Components of Impedance 
2.4.1 Impedance Spectrum Measurement for a Microfluidic System 
An impedance measurement setup for a microfluidic system typically consists of at least two 
electrodes within an electrode cell which contains the test sample. An impedance analyzer is 
connected to the electrodes to perform an impedance scan. A schematic of the impedance 
measurement scheme is shown in Figure 2.17. The impedance analyzer applies an AC voltage 
perturbation and the current flows through all components of the system, the electrodes, the 




Figure 2.17 Impedance spectrum measurement setup for a microfluidic system 
The measured impedance is therefore the sum of the contributions from all the components of 
the system. Some of the latest impedance analyzers also contain post-processing capabilities to 
perform equivalent circuit analysis. The impedance spectrum is measured as a function of the 
concentration of the analyte in the suspension medium. The frequency range of the impedance 
measurement can vary with the system under study but usually ranges from 5 Hz up to 10 MHz. 
The suspension medium can be used as the control/reference in impedance measurement. The 
impedance data for various analyte concentrations is compared with the control data to determine 
the change in impedance caused by the presence of analyte in the suspension medium.  
2.4.2 Design of Interdigitated Electrode (IDE) 
The electrode configuration for impedance measurement can be IDE, double or triple electrodes.  
The choice of electrode material is also important because it can affect the chemistry and ease of 
functionalization of the electrode surface.  Other selection criteria include durability and stability 
under measurement conditions, the possibility of cleaning and sterilizing the electrode surface 
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and biocompatibility. The most common electrode material is gold, but platinum and carbon 
electrodes have also been reported. Gold is a very good electrode material due to its relatively 
fast electrode kinetics and the possibility of forming self-assembled monolayers (SAM) to 
immobilize biorecognition element on the electrode surface. IDE is highly desirable in 
impedance measurement because of its well-defined geometry and reproducibility in fabrication 
[159]. IDE consists of multiple leads with branched electrode fingers interwoven between the 
leads [160]. Figure 2.18a shows a basic IDE configuration, including the electrical contact pads, 
side rails and interdigitated fingers. Figure 2.18 (b) shows the various design dimensions of an 
IDE configuration. In Figure 2.18 (b), L is the length of the electrode finger, W is the width of 
the electrode finger, S is the spacing between the electrode fingers, G is the gap between side rail 
and finger, A is the width of bond pad, B is the length of bond pad, C is the length of connection 
between bond pad and side rail. Figure 2.19 shows the various layers of an IDE chip assembly. 
The sensing area of the IDE is the region between the opposing electrode rails. The performance 
of the IDE for impedance measurements in a microfluidic chamber depends on the geometric 
design of the IDE and can be significantly impacted by variability or defects in manufacturing or 
material [160]. Several IDE configurations were designed and included alterations to the width 
of the electrodes, spacing between electrodes and the number of pairs of electrodes. The 
electrode material was gold for all designs. Table 2.11 lists the various IDE configurations used 


















Figure 2.18 (a) Basic IDE features (b) Dimensions of IDE 
Name N S (µm) W(µm) L(mm) A(mm) B(mm) C(mm) G(µm) 
Design 25-10 20 20 20 0.9 4 4 16.6 50 
Design 25-ext 50 20 20 2.83 4 4 16.6 100 
Design 25-int 50 20 20 0.89 4 4 16.6 50 
Circular 50 20 20 0.79-1.75 4 4 17 50 
 


















Figure 2.19 Various layers of an IDE chip assembly 
2.5 Magnetic Separation Techniques 
The magnetic force acting on a single magnetic particle is given by [161] 





                          (2.2) 
where     is the magnetic density gradient,   is the susceptibility of the magnetic particle,   is 
the volume of the magnetic particle, and    is the permeability of free space. If the magnetic 
particle moves in a suspension medium, it also experiences the hydrodynamic drag       and 
gravitational forces    and can be calculated using the following equations. 
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where   ,        ,    and         are the particle velocity, medium velocity, particle density 
and medium density, respectively. Solving for (          ) for a particle with radius R,  
(          )    
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The hydrodynamic drag force is the most significant force acting against the magnetic force on 
the bead.  The magnetic capture force will dominate when  
                                                                                                                                        (2.6)                  
2.6 Integration of Micropump, Micromixer, and IDE 
A systematic study was carried out to determine the performance of the various designs of 
micropumps and micromixers. Based on the results (to be discussed in Chapter 5), Design3 of 
micropump and Design3 of micromixer were selected for the fully integrated microfluidic 
system. The fully integrated microfluidic system consists of a PDMS control layer with the 
micromixer and micropump, a PDMS fluidic layer with the mixing chamber and an IDE on glass 
substrate. The PDMS fluidic layer and the IDE on glass substrate are aligned such that the 
mixing chamber covers the IDE. Figure 2.20 shows the various layers of the fully integrated 
microfluidic system. Figure 2.21 shows the outer dimensions of the control layer. Figure 2.22 
shows the dimensions of the fluidic layer. Figure 2.23 shows the outer dimensions of the IDE 





Figure 2.20 Different layers of the fully integrated device assembly 
 
 















         
 
Figure 2.22 Outer dimensions of the fluidic layer         
 
       
                                         
Figure 2.23 Outer dimensions of the IDE layer         
 
               






















2.7 Biotin-Streptavidin Interactions in Assay Systems 
Streptavidin is a protein with four identical subunits, each containing a high affinity binding site 
for biotin (also known as vitamin H). The dissociation constant KD of the biotin-streptavidin 
complex is on the order of ~10
-15
 which is among the strongest non-covalent interactions known 




 times greater than the interaction of ligands with their specific 
antibodies [162]. This high dissociation constant ensures that once a streptavidin-avidin complex 
is formed, the complex is not affected by any pH changes, presence of chaotropes, or any 
washing steps required for the protocol. The biotin-streptavidin interaction is a widely used 
affinity pair in molecular, immunological, and cellular assays. The specificity of biotin-
streptavidin complex has been used as a basis for developing assay systems to detect or quantify 
analytes. A common application for biotin-streptavidin interaction is in immunoassays. The 
specificity of antibody molecules provides the targeting capability to recognize and bind 
particular antigen molecules. If biotin labels are attached to the antibody, and the streptavidin is 
in turn labeled with a signal generating substance such as an enzyme or fluorophore, then a very 
sensitive antigen detection system can be created based on the biotin-streptavidin reaction. 
2.7.1 Biotin-Streptavidin Conjugation Reaction 
The biotin-streptavidin conjugation reaction was utilized in the present study to determine the 
performance of the micromixer and also to test the fully integrated microfluidic system for the 
detection of biotin conjugated fluorescent (BCF) microbeads. In this study, two surface 
functionalized beads were used: BCF microbeads and streptavidin conjugated paramagnetic 
(SCP) microbeads. The details of the BCF and SCP microbeads are mentioned in Chapter 4. 
After mixing, the biotin-streptavidin complex can be magnetically separated as depicted in 
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Figure 2.25 and the fluorescence signal from the biotin coated fluorescent beads can be measured 
using a fluorometer to estimate the quantity of the biotin-streptavidin microbead conjugates. The 
intensity of the fluorescence signal indicates the extent of the binding reaction between the two 













Figure 2.25 Biotin Streptavidin conjugation reaction  
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BCF  bead 
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2.8 Insulin Detection 
The fully integrated microfluidic system was tested for the immuno microbead based insulin 
detection. The details of all the chemicals, microbeads, type of insulin and insulin antibody used 
are mentioned in Chapter 4. Figure 2.26 shows the various steps used in preparation of samples 
and the insulin detection protocol used in the present study.  
The carboxyl groups on the surface of the microbeads are first activated by combining with 
EDC.  The activation of the carboxyl groups allows it to covalently attach to the amine groups on 
antibodies. The activated magnetic beads are combined with the unconjugated mouse anti-insulin 
(1G11) monoclonal antibody (MAI-Ab) to yield Magnetic Beads-Antibody Conjugate (MBAC).  
The prepared MBAC is then mixed with target insulin molecules to allow binding reaction 
between target insulin molecules and MAI-Ab. An external magnet is used to separate the 
MBAC-target insulin complex from the solution. The unbound target insulin molecules are 
removed by washing with a buffer solution. The wash step is followed by an impedance 





Figure 2.26 Basic steps in insulin sample preparation (a) Introduction of MBAC target insulin, 
(b) mixing and binding of the target insulin to MBAC (c) magnetic separation of the target 











The microfabrication methods for the various components of the microfluidic system are 
described in detail in this chapter. The microfluidics components including the microchannel, 
microvalve, micropump and micromixer were fabricated by soft lithography rapid prototyping of 
PDMS and SU-8 photoresist. The microelectrodes for the impedance detection module were 
fabricated by traditional MEMS based micromachining of Chrome/Gold thin-film layer on a 
glass substrate. 
3.1 PDMS Soft Lithography 
Figure 3.1 demonstrates the process flow used to fabricate the PDMS components. The actual 
fabrication was performed at the High Density Electronics Center (HiDEC) of the University of 
Arkansas and the Arkansas Micro and Nano Systems Laboratory. The details of the process flow 
shown in Figure 3.1 are provided in the following sections. 
3.2 Mask Design 
All mask designs were drafted using AutoCAD. The mask size was designed to be compatible 
with 5 inch wafers. The AutoCAD designs were sent to Advance Reproductions (North Andover, 
MA) where transparency photo masks with a ¼ mil resolution were manufactured.  The 
transparency photo mask is suitable for designs at a resolution limit of about 15µm. Each photo 













3.3 Fabrication of SU-8 Master Mold 
Using the transparency masks, SU-8 master molds were fabricated for casting PDMS. The 









         









Figure 3.2 Fabrication of SU-8 mold 
The details of the processing steps are described in the following sections. 
Si wafer 1. Clean silicon wafer 
SU-8 2.  Spin coat SU-8 and 
     planarize  
3.   Pre-exposure bake   
       Hot Plate 
4. UV exposure using    
    mask aligner to    






5.   Post-exposure bake   
       
Hot Plate 
6. Develop in SU-8 developer 
Hot Plate 
7.  Hard bake        
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1. A piranha solution was prepared by mixing H2SO4 with H2O2 at the ratio 3:1 and 
heated on a hotplate to a temperature of 150ºC. Afterwards, the silicon wafer for the 
SU-8 mold was immersed in it for 15 min. Next, the silicon wafer was dump rinsed in 
DI water followed by spin rinse and drying. The silicon wafer was then placed in a 
buffered oxide etchant (BOE, HF: NH4F= 1:6) solution to strip any silicon dioxide on 
the wafer. The silicon was dump rinsed again in DI water followed by spin rinse and 
drying. The silicon wafer was placed in an oven for 20 min at 120ºC to remove any 
moisture on the wafer surface. 
2. The cleaned silicon wafer was mounted on the vacuum chuck of the negative resist 
spin coating system. Then approximately 5 mL of liquid SU-8 2075 (MicroChem 
Corp., Newton, MA) was dispensed onto the center of the silicon wafer. The wafer 
was spun at 500 rpm for 10 seconds followed by 2000 rpm for 30 s to obtain a SU-8 
thickness of 100 µm.  The spin speed and spin time information was obtained from 
the SU-8 2075 data sheet provided by the vendor. After spin coating the wafer was 
placed on a flat surface to allow the SU-8 to flow and planarize uniformly across the 
wafer surface. This step is very important especially with thin silicon wafers which 
bend because they are pulled at the center when placed on the high vacuum chuck of 
a spin coater. The absence of edge bead removal during the spin coating step will also 
require the planarization step. 
3. The pre-exposure bake step was performed in two steps, first step at 65ºC for 5 
minutes followed by a second bake step at 95ºC for 20 min. These temperatures and 
timings depend upon the thickness of the SU-8 and can information can be obtained 
from the data sheet.  The hot plate was then turned off to allow the wafer to cool 
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down slowly to room temperature. The slow cooling of the wafer is important to 
prevent resist cracking and possible delamination. 
4. The wafer with SU-8 coating was mounted on a Karl Suss Mask aligner and a 
transparency mask with design pattern was placed and aligned on top of the wafer. In 
order to obtain vertical side walls in the SU-8 photoresist, a UV filter (PL-360-LP, 
Omega Optical, Inc., Brattleboro, VT) to filter out UV radiation below 350 nm, was 
placed between the UV light source and the transparency mask. The UV exposure 
energy value required for a 100 µm thick SU-8 2075 is 240 mJ/cm
2
 and was obtained 
from the SU-8 data sheet. The exposure time was calculated based on the intensity of 
the UV lamp source and was incremented by 20% to account for the presence of the 
UV filter. 
5. The post-exposure bake was performed on a hotplate in a two-step process to stabilize 
the transferred pattern and remove any extra solvents. The first bake step was 
performed at 65ºC for 5 min, followed by a second bake step at 95ºC for 10 min. The 
hot plate was then turned off to allow the wafer to cool down slowly to room 
temperature. 
6. The wafer was immersed in a SU-8 Developer (MicroChem Corp., Newton, MA), 
developed for 10 min (for 200 µm thick SU-8) and gently moved back and forth to 
ensure uniform developing. The wafer was rinsed briefly with IPA and blown dry 
with nitrogen. 
7. The dried wafer is then hard baked on a hot plate at 150°C for a couple of minutes to 
complete the SU-8 patterning process. 
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3.4 Thick PDMS Casting 














Figure 3.3 Thick PDMS casting process  
The details of the thick PDMS casting process are as follows: 
1. The PDMS base and curing agent were mixed in a ratio 10:1 by mass in a 2 inch petri 
dish. The PDMS mixture is left in the open petri dish for 15 min to get rid of the air 
bubbles. Alternatively, the petri dish with PDMS mixture can be left in a vacuum 
chamber for a few minutes to degas the air bubbles. 
Hot Plate 
1. Micropump SU-8 
mold 
2. Pour PDMS  and de-gas 
3. Cure PDMS at 80°C for 2 hours. 





2. For the thick PDMS layer, the PDMS mixture is poured uniformly to cover the wafer 
with the SU-8 mold to a thickness of approximately 5 mm. Any air bubbles generated 
while pouring were removed by piercing the bubbles with a syringe needle.  
3. The SU-8 mold was then placed on a hot plate at 80ºC for 2 hrs.  
4. The cured PDMS layer was diced using a razor blade and gently peeled off from the 
SU-8 mold to obtain the thick PDMS component. 
Figure 3.4 (a) shows a typical SU-8 mold for a micropump fluidic layer. Figure 3.4 (b) shows a 
thick PDMS layer casted by SU-8 mold. 
                 
Figure 3.4 (a) Typical SU-8 mold on Si wafer (b) A thick PDMS fluidic layer  
 
3.5 Thin PDMS Casting 




















Figure 3.5 Thin PDMS casting process 
The details of the thin PDMS casting process are as follows:  
1. PDMS mixture was prepared as described in the previous section. 
2. For the thin PDMS layers with membranes, the PDMS mixture was spin coated on 
the SU-8 mold at 450 rpm for 1 min to obtain a 100 µm thick PDMS membrane. The 
required spin speed was determined from the spin speed vs. thickness plot [163] as 
shown in Figure 3.6. 
2. Spin coat PDMS to obtain thin 
layer and degas 
3. Cure PDMS at 80°C for 2 hours 
Hot Plate 
1. SU-8 mold 





Figure 3.6 PDMS thickness as a function of spin speed 
3. The SU-8 mold was then placed on a hot plate at 80ºC for 2 hrs. 
4. The cured PDMS layer was diced using a razor blade and gently peeled off from the 
SU-8 mold to obtain the thin PDMS component. 
Figure 3.7 (a) shows a typical SU-8 mold for a thin PDMS control layer. Figure 3.7 (b) shows a 
thin PDMS layer casted by SU-8 mold. 
 




3.6 Oxygen Plasma Bonding 
The bonding of a PDMS layer to another PDMS layer or a PDMS layer to a glass substrate was 
achieved by oxygen plasma treatment of the bonding surfaces. The PDMS thin layer was first 
bonded to a glass slide which provides mechanical support. The PDMS thick layer was then 
bonded to the PDMS thin layer. A glass slide was then bonded to the PDMS thick layer. Figure 
3.8 shows the process flow for assembling the device.  
 
Figure 3.8 Process flow for assembling the device 
The oxygen plasma bonding steps are as described below: 
1. An abrasive diamond grinding mandrel (1.5 mm diameter, Wale Apparatus Inc., 
Hellertown, PA) was used to drill holes in the glass slides (75x38 mm, 1 mm 
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thick, Electron Microscopy Sciences, Hatfield, PA) for providing access to the 
inlets and outlets of the microchannels in the PDMS layer. The glass slides with 
drilled holes were cleaned using a Piranha solution to remove any organic 
contaminants, rinsed in DI water and blow dried with nitrogen A 1.5 mm tip 
diameter micro coring tool (Harris uni-core, Ted Pella, Inc. Redding, CA) was 
used to punch holes in the PDMS layers at the microchannel inlet and outlet. The 
glass slide and the thin PDMS layer were placed inside the Oxygen plasma 
chamber (Model PC-150, South Bay Technology, Inc., San Clemente, CA) with 
their bonding sides facing up. The plasma chamber was operated at 20 W, 105 
mTorr for 20 s. The exposure to oxygen plasma causes oxidation of the CH3 
groups on the PDMS surface to produce OH groups [164]. The –OH functional 
groups on the PDMS surface enable bonding to another PDMS surface or glass. 
The oxygen plasma treatment also temporarily makes the hydrophobic PDMS 
surface to a hydrophilic surface. The plasma treated PDMS layer was held by a 
pair of tweezers at the opposite corners, aligned and brought in contact with the 
glass slide on one edge of the glass slide first. The PDMS layer was then gently 
rolled on top of the glass slide to complete the bonding as shown in Figure 3.9. 
This rolling action reduces the trapping of air between the bonded layers and 
leads to a uniform bonding. The bonding process has to be completed within 3 




Figure 3.9 Roll PDMS layer to obtain uniform bonding 
2. A 1.5 mm tip diameter micro coring tool was used to punch holes in the thick PDMS 
layers at the microchannel inlet and outlet. 
3. A similar procedure as described in Step 1 was repeated to bond the thick PDMS 
layer to the thin PDMS layers.  
4. A glass slide was then bonded to the thick PDMS layer to complete the oxygen 
plasma bonding process for the device. The assembled device was then packaged 
with fluidic connectors and tubing to obtain the final device.  
Figure 3.10(a) shows typical thick and thin PDMS layers of a micropump assembled together 
and Figure 3.10(b) shows a close view of the alignment of the air chambers on top of the 
microchannel.
 
Figure 3.10 Thick and thin PDMS layers of a micropump bonded together (b) A close view of 




3.7 Fabrication of IDE 















Figure 3.11 Fabrication steps for IDE 
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6. Strip resist, rinse  
   with DI water and dry 
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The AutoCAD designs were sent to Advance Reproductions (North Andover, MA) where 
transparency photo masks with a ¼ mil resolution were manufactured.  The transparency photo 
mask is suitable for designs at a resolution limit of about 15 µm. The wafers used were 500 µm 
thick, 5 in. Glaverbel float soda lime glass wafers (Precision Glass and Optics, Santa Ana, CA).   
  The details of the processing steps are as described below. 
1. The wafers were cleaned in a Piranha solution, rinsed in DI water and spin dried. The 
cleaned wafers were then sputtered with Cr/Au (250Å/5000Å, UHV Sputtering,Inc., 
Morgan Hill, CA). The glass wafers with Cr/Au were rinsed with Acetone, rinsed in 
DI water and spin dried. The wafers were then left in an oven at 120°C to dry the 
wafer surface. The cleaned wafers were spin coated with a 1.25 µm thick layer of 
AZ4110 photoresist. After the spin coating, the resist may contain up to 15% solvent 
and may have built-in stress. To remove the solvent and reduce the stress, the spin 
coated resist was soft baked at 110°C for 4 min.  
2. Following this, a Karl Suss mask aligner was used to align and expose the resist 
coated wafer to transfer the pattern from the photomask onto the photoresist.  
3. Afterwards a development process was used to selectively dissolve the photoresist. 
AZ4110. Following development, the wafer was examined visually to ensure that the 
development process was complete. A final inspection was made under a microscope 
to ensure that the pattern obtained was as expected.  
4. Hard bake or post bake removes any residual developer solution and also anneals the 
photoresist to promote the interfacial adhesion of the photoresist weakened by 
developer entering the resist-wafer interface. Hard baking also improves the hardness 
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of the film which is required during further etching steps. The hard bake was carried 
out by placing the wafer in an oven at 120°C for 15 min. 
5. The wafer was immersed in a gold etchant solution (gold etchant TFA, Transene, Inc, 
Danvers, MA) to remove the gold from the exposed regions on the wafer. The etch 
rate was 28Å/second at 25°C when the etchant was fresh. This was followed by a Cr 
etch using the chromium etchant (1020AC, Transene, Inc.) to remove the chrome 
layer. The etch rate was 32Å/s at 40°C.  
6. The etched wafers were rinsed with DI water and spin dried. 
Figure 3.12 shows a typical IDE chip with holes drilled for access to the inlet and outlet of the 
fluidic layer microchannel. Also shown is a close view of the IDE fingers with 10 µm width and 
spacing. 
 
Figure 3.12 A typical IDE chip with a close view of the IDE fingers 
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3.7.1 PDMS bonding with IDE 
The etched wafers were then diced using a wafer dicing machine to obtain the individual 











Figure 3.13 PDMS bonding to IDE 
The details of the processing steps are as described below: 
1. An abrasive diamond grinding mandrel was used to drill holes in the electrode 
chip to provide inlet and outlet access. The electrode chips were rinsed in DI 
water and blow dried with Nitrogen to remove the glass debris produced 
during the drilling process. The electrode chips were then rinsed in Acetone 
and blow dried with Nitrogen. A PDMS microchannel was bonded to the 
electrode chip by using oxygen plasma bonding method as described in the 
previous section.  
Glass 
Cr/Au electrodes 







   
1. Drill access holes and clean. 
2. PDMS channel – O2 plasma bonding 
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2. A glass layer was bonded to the PDMS layer to provide mechanical stability. 
3.8 PDMS – Glass Thermal Bonding 
An alternate method to oxygen plasma bonding is thermal bonding. Thermal bonding provides a 
temporary bond unlike the permanent bond achieved through oxygen plasma bonding. Figure 











Figure 3.14 PDMS – Glass thermal bonding process 
The details of the processing steps are as described below: 
1. The PDMS microchannels were casted on a SU-8 mold as described in the 





   
2.   Align PDMS microchannel on 
electrode chip with holes drilled 
for inlet and outlet. 
Partially cured 
PDMS microchannel  
1. Cast PDMS microchannel and 
partially cure at 65°C 
Cr/Au electrodes 
Glass    
Hot Plate 3. Final cure at 80°C for 10 hours 
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2. An abrasive diamond grinding mandrel was used to drill holes in the electrode 
chip to provide access to the inlet and outlets of the PDMS microchannel. The 
electrode chips were rinsed in DI water to remove the glass debris produced 
during the drilling process. The electrode chips were then rinsed in acetone to 
remove the photoresist. After the acetone rinse most of the photoresist from 
the electrode surface is removed. To further clean the electrode surface, a soft 
cotton swab dipped in acetone was used to gently clean the electrodes without 
scratching the gold surface. The partially cured PDMS is peeled off the SU-8 
mold, aligned with electrode chip and aligned on top of the electrode chip.  
3. The electrode chip with PDMS is then place on a hot plate at 80°C for 10 hrs 
to completely cure the PDMS layer. After the final curing, a glass slide is 
attached to the exposed back side of the PDMS channel to provide mechanical 
support.  
The thermal bonding method, unlike the oxygen plasma treatment bonding method, is reversible. 
Therefore, the PDMS layer can be removed and replaced with a fresh PDMS layer when PDMS 
surface is contaminated after repeated use or when it is required to clean the electrode surface. 
3.9 Fully Integrated Microfluidic System 
Figure 3.15 shows a fully integrated microfluidic system. Figure 3.16 shows a close view of the 













Figure 3.15 A fully integrated microfluidic system 
 
 
Figure 3.16 A close view of the various components on the fully integrated system   
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4. EXPERIMENTAL SETUP AND TESTING 
The following sections describe the material selection and design of experimental methods used 
to test the various microfluidic system components used in this study. The focus will be on 
individual testing of various microfluidic components and the integration of various components 
to achieve a fully integrated microfluidic system. 
4.1 Surface Modification of PDMS  
The use of PDMS for microfluidic devices has many advantages as discussed in the previous 
section. However, PDMS has a hydrophobic surface and tends to adsorb organic macromolecules 
such as protein and causes non-specific protein adsorption which can interfere with biological 
applications performed within a PDMS microfluidic system [165]. The hydrophobic surface of 
PDMS also leads to formation of air bubbles within a PDMS microchannel. One of the methods 
commonly used to modify the hydrophobic surface of PDMS by exposure to oxygen plasma. An 
exposure to oxygen plasma oxidizes the surface of the PDMS and makes it hydrophilic. 
However, when exposed to air later, the hydrophobic surface recovers with time. With oxygen 
plasma treatment, a useful lifetime for quantitative electrophoresis is 3 hrs [166]. In the present 
study, the PDMS surfaces were treated with Pluronic F108 surfactant (#F018, BASF, Florham 
Park, New Jersey) to modify the PDMS surface to make it hydrophilic and reduce non-specific 
protein adsorption. Pluronic belongs to a group of triblock copolymers with poly(propylene 
oxide) (PPO) centers with poly(ethyelene oxide) (PEO) side chains with the general composition 
of (PEO)m(PPO)n(PEO)m, which has been proven to have extremely low toxicity and 
immunogenic response and is widely used in many biotechnological applications [167]. In this 
approach, the PDMS microchannels were filled with Pluronic F108 surfactant solution and 
allowed to incubate for at least 1 hour. The concentration of Pluronic F108 solution used was 1% 
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weight in water, prepared by mixing 1 g of Pluronic F108 in 100 mL of DI water. This surface 
modification reduced the hydrophobic forces and enhanced the fluid movement through the 
microchannels. The surface modification also reduced the formation of air bubbles within the 
microfluidic channels. The surface modification lasted for a few days when compared to oxygen 
plasma treatment method with a lifetime of only 3 hrs. 
4.2 Micropump Performance Testing 
The control system for operating the micropump consists of a mini air compressor (BTC-IIS, 
part# D730A-23-01, Hargraves, Mooresville, NC) to supply compressed air and a 3-port ultra-
miniature solenoid valve (S070C-5BG-32, SMC Pneumatics, Noblesville, IN) to control the 
supply of compressed air. Figure 4.1 shows the mini air compressor and 3-port ultra-miniature 
solenoid valves used. A pressure regulator with a gauge was used to regulate the compressed air 
supply to the micropump. The mini air compressor is 3 x 3 x 1 in size and weighs only 170 
grams. The ultra-miniature solenoid valve is 7 x 30 x 11 mm in size and weighs only 5 g. Both 
the mini air compressor and the solenoid valve are compact, lightweight and these are desirable 
characteristics for portable devices. A DC power supply was used to power the mini air 
compressor with a voltage of 24 V DC. A function generator (HP 3325B) was used to power the 
solenoid valve with a square wave form AC signal of 12 V peak to peak with 6V DC offset.  The 
outlet of the micropump was connected to tubing with 1/8” ID. Figure 4.2 shows a schematic of 




                                               
Figure 4.1 (a) 3-port ultra-miniature solenoid valve (SMC part# S070C-5BG-32) (b) Mini Air 




Figure 4.2 Schematic of experimental setup layout for micropump performance testing 
The two main control parameters that affect the performance of the micropump are the pressure 
of the compressed air and the actuation frequency of the solenoid valve. The micropumps were 
tested with three compressed air pressures, 10, 20 and 30 psi. For each pressure, the frequency of 
operation of the solenoid valve was varied and six frequencies were used, namely, 5, 10, 15, 20, 




performance testing. Figure 4.4 shows the test fixture with various components. Figure 4.5 
shows the various tubing connections on the 3-port solenoid valve. The microfluidic channel of 
the micropump was first treated with Pluronic F108 solution for 2 hrs. The micropump was then 
primed with DI water and the initial position of the water front in the outlet tubing was noted on 
the ruler placed next to the tubing. Figure 4.6 shows the micropump clamped on the test fixture. 
The micropump was operated for 3 minutes and the final position of the water front within the 
outlet tubing was noted on a ruler. Figure 4.7 shows the initial and final positions of the DI water 
front (shown with a green dye for better visibility). The change in position of the water front 
within the tubing (ΔL) was used to compute the volume of the fluid displaced (ΔL x cross-
sectional area of tube based on inner diameter) by the micropump. All three micropump designs 






























Figure 4.5 3-port solenoid valve with tubing connected to pressure source and micropump 
 












Figure 4.7 (a) Initial position of DI water front (b) Final position of DI water front 
 
4.3 Micromixer Performance Testing  
The experimental setup layout for micromixer performance testing is very similar to that of the 
micropump. The micromixer fluidic layer has two inlets to the mixing chamber and one outlet 
for collecting the mixed sample. Three micromixer designs were tested and the performances of 







sample flow rate. Figure 4.8 shows a schematic of the experimental setup layout for micromixer 
performance testing. Figure 4.9 shows the experimental set up on an optical table for micromixer 
performance testing. 
 
Figure 4.8 Schematic of an experimental setup layout for micromixer performance testing 
 
Figure 4.9 Experimental setup for micromixer performance testing 
Syringe pump 





Figure 4.10 shows a test fixture with various components. Figure 4.11 shows a micromixer 
clamped on the test fixture. 
 
Figure 4.10 Test fixture with various components 
 




Streptavidin-biotin conjugation reactions were used to characterize the mixers’ performance and 
also test the fully integrated microfluidic system. BCF microbeads (Catalog# 24173-1, 
Fluoresbrite® Yellow Green fluorescent 2.0 μm diameter, 2.41×10
9
 beads/mL) were purchased 
from Polysciences, Inc (Warrington, PA). The fluorescent yellow green BCF beads have an 
excitation maximum wavelength of 441 nm and an emission maximum wavelength of 486 nm, 
similar to FITC. SCP microbeads (Dynabeads® M-270 Streptavidin, 2.8 μm diameter, 6.7×10
8
 
beads/mL, Catalog# 653-05) were purchased from Life Technologies (Grand Island, NY) 
4.3.2 Sample Preparation 
A 150 µl sample of BCF microbeads was dispensed into a microcentrifuge tube and centrifuged 
at 10,000G for 5 min in a table top centrifuge. The supernatant was then removed and discarded. 
The BCF microbeads were resuspended in phosphate buffered saline (PBS) with pH 7.4.  This 
step was repeated three times to wash the BCF beads. After the last wash, a 1.5 mL BCF sample 
was prepared by mixing 150 µL of BCF beads with 1350 µL of PBS buffer. At this dilution, the 
number of BCF microbeads was calculated to be 2.4×10
8
 microbeads/mL. A 100 µL of SCP 
microbeads was mixed with 1400 µL of PBS in a microcentrifuge tube and placed in a magnetic 
separation stand (MagneSphere®, Promega Corp., Madison, WI) for 2 minutes. After 2 minutes 
the supernatant was aspirated with a pipette while the microcentrifuge tube was still held in the 
magnetic separation stand. The microcentrifuge tube was then removed from the magnetic 
separation stand and 1500 µL of PBS buffer was added along the inside of the microcentrifuge 
tube where the microbeads are collected. The washing procedure was repeated three times. At 





Streptavidin is a tetramer with four binding sites. The ratio of BCF microbeads to SCP 
microbeads is 5.4 and this ensures that the SCP microbead binding sites for biotin are saturated. 
4.3.3 Micromixer and Table Top Mixer Comparison 
The effect of mixing on streptavidin-biotin conjugation reaction was studied using both a table 
top mixer (Thermomixer®R, Eppendorf, NY) and a Design1 micromixer. For table top mixer, a 
30 μL BCF microbead sample was added to a 30 μl SCP microbead sample in a centrifuge tube. 
The centrifuge tube was then mounted on the table top mixer and the sample was mixed for 15 
min at 600 rpm. For micromixers, a syringe pump (PHD 2000 Programmable, Harvard 
Apparatus, MA) was used to continuously inject the BCF microbeads and SCP microbead 
samples into their respective inlets in the micromixer. The flow rate was 1 μL/min and the 
solenoid valve was actuated at a frequency of 10 Hz. A 20 μL mixed sample from the 
micromixer outlet was collected in a centrifuge tube for fluorescence measurement. 
4.3.4 Performance Testing 
For the frequency test, the flow rate of the samples was held constant at 2 μL/min, while the 
fluorescence measurements were made for various solenoid actuation frequencies in the range of 
5 to 15 Hz. For the flow rate test, the solenoid actuation frequency was held constant at 10 Hz, 
while the sample flow rates were varied in the range of 1.2 - 4.0 μL/min.  The BCF microbeads 
and SCP microbead samples were injected simultaneously into the micromixer using a syringe 
pump and the mixed sample was collected at the outlet for fluorescence measurements. 
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4.3.5 Fluorescence Measurements 
A VersaFluor benchtop Fluorometer (BIO-RAD Hercules, CA) was used for all fluorescence 
measurements. Figure 4.12 shows the VersaFluor fluorometer and the interior section with 
microcuvette and excitation and emission filters. The excitation and emission filters used in the 
fluorometer were EX 490/10 nm and EM 520/10 nm respectively. The fluorometer was turned 
ON for 30 min before any measurements were made.  
 
Figure 4.12 (a) VersaFluor Fluorometer (b) a microcuvette with test sample inserted in the 
cuvette holder and also shown are the excitation and emission filters 
 
A 20 μL BCF microbead sample was diluted with 200 μL PBS buffer in a microcuvette and 
labeled as the pre-coupling BCF microbead sample. The microcuvette was placed in the 
fluorometer and fluorescence signal was recorded. The BCF-SCP conjugated microbeads 
solution was transferred to a microcuvette and labeled as the post-coupling sample. The 
microcuvette was inserted into the microcuvette holder of the fluorometer to measure the 
fluorescence signal intensity of the sample in RFU.  Because of the magnetic separation, only 
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those BCF beads which bonded with the SCP beads remain to give off a fluorescence signal.  
The concentration of the fluorescent beads is directly proportional to the intensity of the 
fluorescence signal. The pre-coupling RFU values were compared with the post-coupling RFU 
values to estimate the coupling efficiency. Therefore, the fluorometer reading in RFU is a good 
indicator of the binding efficiency of the biotin-streptavidin beads conjugation reaction. 
4.4 Integrated System of Micromixer and Micropump 
The integrated micropump-micromixer system was first treated with Pluronic solution for 2 
hours. The performance of the micropump was characterized by a method as described in the 
previous section. Figure 4.13 shows a schematic of the experimental setup layout for testing the 
integrated micropump-micromixer system for streptavidin-biotin conjugation reactions. Figure 
4.14 shows the experimental setup on an optical table for testing integrated micropump-
micromixer. integrated micropump-micromixer clamped on a test fixture. The two solenoid 
valves were separately controlled using individual function generators. Figure 4.15 (a) shows the 
test fixture with various components. Figure 4.15 (b) shows an integrated micropump-
micromixer system clamped on the test fixture. The test samples for BCF and SCP microbeads 
were prepared as described in the previous section. The BCF and SCP microbead samples were 
introduced into their respective inlets with the micropump and micromixer in operation. A 20 µL 
sample collected from the outlet was transferred via a pipette to a 100 µL PBS buffer in a 
centrifuge tube. The centrifuge tube was then placed in a magnetic separation stand for 2 min. 
After 2 min, the supernatant was aspirated and discarded while the centrifuge tube was still in the 
magnetic separation stand. The centrifuge tube was removed from the magnetic separation stand 
and 100 µL of PBS was added along the insides of the centrifuge tube where the separate 
microbeads are collected. This washing step was repeated three times. After the washing step, 
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BCF-SCP microbead conjugates were resuspended in 200 µL of PBS for fluorescence 
measurements. The micromixer mixing performance based on streptavidin-biotin conjugation 
reaction was tested with respect to solenoid actuation frequency, compressed air pressure and 
















Figure 4.15 (a) A test fixture for integrated micropump-micromixer testing (b) An integrated 




4.5 Impedance Spectrum Measurement 
Impedance spectrum measurements were performed using a HP 4192A LF impedance analyzer.  
For all impedance measurements, a sine modulated AC potential of 100 mV was applied across 
the interdigitated electrodes and the magnitude and phase angle of impedance were recorded for 
a frequency sweep from 10 Hz to 10 MHz. The impedance analyzer was controlled using a 
labVIEW program (LabVIEW 8.0) installed on a laptop and interfaced with the impedance 
analyzer via a GPIB connection. A labVIEW plug and play instrument driver for HP4192A was 
downloaded from National Instruments website and modified to perform a log sweep. The 
downloaded driver was originally designed for performing a linear scan. In order to perform a 
log scan, the block diagrams of “HP4192A Example.vi” and “Measure.vi” components of the 
downloaded driver was modified. The screenshots of the block diagram of the modified VI’s are 
shown in Figure 4.16 and Figure 4.17 respectively. The data acquired from the impedance 
analyzer was stored in an excel file format for further processing. 
 




Figure 4.17 Modified block diagram of Measure.vi 
4.6 Magnetic Microbead Separation 
4.6.1 Magnet Selection 
Two approaches for magnetic separation of paramagnetic beads were studied. The first approach 
was to use an electromagnet. Electromagnets of three different sizes and magnetic strength were 
purchased from Rochester Magnet Co. (East Rochester, NY). The second approach was to use 
permanent magnets. Neodymium disc permanent magnets of three different sizes and magnetic 
strength were purchased from Rochester Magnet Co. Table 4.1 and Table 4.2 show the list of 
permanent magnets and electromagnets respectively with their dimensions and magnetic field 
strength ratings. Figure 4.18 shows the various electromagnets and permanent magnets listed in 








Magnet Diameter × Thickness (in) 
Magnetic Field 
Strength (mT) 
PM1 0.190 x 0.125 480 
PM2 0.220 x 0.100 400 
PM3 0.500 X 0.060 140 
 
Table 4.1 Specification of permanent magnets  
 
Magnet Diameter × Height (in) 
Magnetic Field 
Strength (mT) 
EM1 1.25 x 1.25 70 
EM2 1 x 1.25 120 
EM3 0.500 x 1.5 80 
 
Table 4.2 Specification of electromagnets 
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4.6.2 Magnetic Separation Testing 
Figure 4.19 shows a schematic of the experimental setup used to test the magnetic separation of 
SCP microbeads. The microfluidic system was mounted on the test fixture and the magnet to be 
tested was positioned below in contact with the microfluidic system. A syringe pump was used to 
inject SCP beads sample at a steady flow rate and was collected at the outlet for inspection. 
Figure 4.20 shows the experimental setup on an optical table for testing the magnetic separation 
of SCP microbeads using an electromagnet. The flow rate of the SCP bead sample was varied in 
the range of 1 - 20 µL/min. A CCD camera mounted on the microscope was used to capture the 
video of SCP microbeads captured within the microfluidic system.  Figure 4.21 (a) shows the test 
fixture with an electromagnet placed on a lab jack and in contact with the microfluidic system 
and Figure 4.21 (b) shows the the top view of the electromagnet in contact with the device. In 
case of electromagnets, a 12 V DC voltage was applied to activate the microfluidic system. The 
applied DC voltage was varied in the range 3 – 12 V to obtain different magnetic field strength 
from the electromagnet. Figure 4.22 (a) and (b) shows the experimental set up used for testing 
the permanent magnets and the top view of the microfluidic system with permanent magnet 




Figure 4.19 Schematic of a setup for testing magnets for magnetic separation of SCP beads 
 
Figure 4.20 Experimental test setup on an optical table for magnetic separation of SCP 




Figure 4.21 (a) Close view of the text fixture showing the electromagnet placed on a lab jack and 




Figure 4.22 (a) Test setup for magnetic separation of SCP beads with a permanent magnet (b) 
Top view of the device with a permanent magnet positioned on top 
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4.7 Fully Integrated System Testing 
The fully integrated system was first tested for impedance detection for various BCF microbead 
concentrations. The fully integrated system was then tested for detecting insulin based on a bead 
based immunoassay to separate insulin from a test sample followed by impedance detection. 
Figure 4.23 shows the schematic of an experimental setup for testing a fully integrated system.  
 
Figure 4.23 Schematic of an experimental setup layout for testing a fully integrated device 
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Figure 4.24 shows an experimental setup on an optical table for fully integrated system testing. 
Figure 4.25 shows the test fixture with various components and Figure 4.26 shows the fully 
integrated system clamped on a test fixture. 
 
Figure 4.24 Experimental test setup for fully integrated microfluidic system 
 




Figure 4.26 Fully integrated microfluidic system clamped on the test fixture 
4.8 BCF Microbeads Detection 
The fully integrated microfluidic system was treated with Pluronic solution to make the PDMS 
surface hydrophilic and also reduced any non-specific protein binding. Figure 4.27 shows the 
process flow for testing streptavidin-biotin conjugation followed by impedance measurement of 
BCF microbeads. The micropump was operated at a flow rate of 2 μL/min and the micromixer 
was operated at 10 Hz, 20 psi conditions. A 20 μL sample of BCF microbead solution and 20 μL 
of SCP microbead solution were introduced in their respective inlets and pumped to the mixing 
chamber. A permanent magnet placed below the IDE was used to attract the SCP microbeads and 
hold them close to the surface of the electrodes. A 20 μL solution of MES buffer was introduced 
at the inlet and a flow rate of 10 μL/min was used to wash away any unbound BCF microbeads 
within the mixing chamber. The wash step was repeated twice. After the wash step, impedance 




    
Figure 4.27 Process flow for BCF microbead detection using the fully integrated microfluidic 
system  
4.9 Insulin Detection 
4.9.1 Preparation of Magnetic Beads-Antibody Conjugate (MBAC) 
A protein coupling kit (BioMag® Plus Carboxyl Protein coupling starter kit, Catalog# 86010-1) 
was purchased from Polysciences, Inc. (Warrington, PA). The kit includes magnetic microbeads 
(BioMag® Plus Carboxyl terminated particles, 2.5 mL, 20 mg/mL, Catalog# 860111-10) 
functionalized with carboxyl group, 0.1 g of EDC (1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide),  15 mL conical centrifuge tubes, a magnetic separator (MultiStep® Biomag 
separator), 25 mL quenching solution, 175 mL MES buffer (pH 5.2, 0.05 M) and 125 mL wash 
buffer. Unconjugated Mouse Anti-Insulin (1G11) monoclonal antibody (MAI-Ab) (Catalog# 
bsm-0855mm, 100 µg lyophilized) was obtained from Bioss , Inc. (Woburn, MA). The carboxyl 
groups on the surface of the microbeads are first activated by carbodiimide which allows the 
amine groups on antibodies to be covalently attached.  
4.9.2 Activation of Carboxyl Groups  
A 0.5 ml (10.0 mg) sample of magnetic microbeads was transferred to a 15 mL conical 
centrifuge tube. The centrifuge tube was inserted into the magnetic separator stand for 3 min to 
allow magnetic separation. The supernatant was then aspirated and discarded. The centrifuge 
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tube was removed from the magnetic separator and a 5 mL MES buffer solution was added. The 
centrifuge tube was then vigorously shaken to mix. The centrifuge tube was inserted into the 
magnetic separator for 3 min to allow magnetic separation. The supernatant was then aspirated 
and discarded.  The washing step with MES buffer was repeated three times. After the final wash 
the magnetic beads were resuspended in 5 ml of MES buffer. The EDC was removed from the 
freezer and allowed to thaw for a minimum of 30 min. The required mass of EDC (1.6 mg 
EDC/mg of magnetic beads) was measured, added to the magnetic beads in solution and mixed 
vigorously on a table top shaker for 30 s. The centrifuge tube was then placed in a shaker (Orbit 
Environ-Shaker model 3527, Lab-Line) at 250 rpm for 30 min at room temperature. It is 
important to not allow the beads to settle during mixing. After mixing the activated magnetic 
beads were magnetically separated on the magnetic separator and the supernatant was aspirated 
and discarded. After the magnetic separation 5 mL of MES buffer was added to the activated 
magnetic beads and shaken on a table top shaker (Touch Mixer model 232, Fisher Scientific, 
Pittsburgh, PA) for 30 s. The activated magnetic beads were magnetically separated on the 
magnetic separator, supernatant was aspirated and discarded. This wash step with MES buffer 
was repeated three times.  
4.9.3 Antibody Coupling 
A 100 µg sample of MAI-Ab in the lyophilized form was reconstituted with 100 µL sterile DI 
water to obtain a stock concentration of 1 µg/ µL.  A 100 µL sample of MAI-Ab solution was 
diluted with 0.5 mL MES buffer. A 50 µl sample of diluted MAI-Ab solution was removed and 
added to 950 µL of MES buffer to obtain a 1:20 dilution “pre-coupling sample” for coupling 
efficiency determination.  The remaining MAI-Ab was added to the activated magnetic beads 
and mixed in a shaker (Orbit environ-shaker model 3527, Lab-line) at 250 rpm for 24 hrs at room 
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temperature to obtain MBAC. After coupling, the MBAC were magnetically separated on a 
magnetic separator. The supernatant was aspirated and saved as the “post-coupling sample” for 
coupling efficiency determination. The MBAC were resuspended in 0.5 mL MES buffer and 
mixed using a table top shaker (Touch Mixer odel 232, Fisher Scientific, Pittsburgh, PA). After 
mixing the MBAC were magnetically separated and the supernatant was aspirated and discarded. 
A 0.5 mL quenching solution was added to the MBAC and mixed in a shaker at room 
temperature for 30 min. After mixing, the MBAC was magnetically separated and the 
supernatant was aspirated and discarded. A 0.5 mL wash buffer was added to the MBAC and 
mixed on a table top shaker. After mixing, the MBAC was magnetically separated and the 
supernatant was aspirated and discarded. This wash step was repeated three times. After the last 
wash, the MBAC were resuspended to 0.2 mL in wash buffer. The MBAC were stored at 4°C as 
a suspension in wash buffer.  
4.9.4 Coupling Efficiency Determination 
In order to determine the coupling efficiency of MAI-Ab and magnetic microbeads, a Quant-
iT™ Protein Assay kit (Life Technologies, Carlsbad, CA) was used. The kit included a protein 
reagent (component A), eight BSA standards of known concentrations (component B) and a 
protein buffer solution (component C).  A protein working solution was prepared by diluting 30 
μL of protein reagent in 5970 μL protein buffer solution to obtain a 1:200 dilution. A 10 μL 
sample of each BSA standard was added to 190 μL of protein buffer solution in a separated 
centrifuge tube to obtain BSA standard test solution and labeled with respective standard 
number. This sample preparation step was performed three times to obtain triplicates of each 
BSA standard test solution and protein working solution. All of the centrifuge tubes with BSA 
standard test solution were shaken on a table top shaker for 3 seconds and then incubated at room 
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temperature for 15 min. After 15 min of incubation, 200 μL of the BSA standard test solution 
were transferred to a microcuvette to perform fluorescence measurements using the Fluorometer. 
This step was performed to obtain three fluorescence readings for each of the eight BSA standard 
test solution. The fluorescence reading of the BSA standard solutions was plotted against their 
respective known concentrations to obtain a standard calibration curve. A 20 μL solution of the 
“pre-coupling sample” was mixed with 180 μL of protein working solution in a centrifuge tube 
to obtain a pre-coupling test solution. This step was repeated three times to obtain a triplicate of 
the pre-coupling test sample. A 20 μL solution of the “post-coupling sample” was mixed with 
180 μL of protein working solution in a centrifuge tube to obtain a post-coupling test sample. 
This step was repeated three times to obtain a triplicate of the post-coupling test sample All of 
the centrifuge tubes were shaken on a table top shaker for 3 seconds and then the samples were 
incubated at room temperature for 15 min. After 15 min of incubation, 200 μL of each sample 
was transferred to a microcuvette to perform fluorescence measurements using the Fluorometer. 
The coupling efficiency was calculated based on the RFU values of the”pre-coupling sample” 
and “post-coupling sample”. 
4.9.5 Insulin Detection 
A 1 M, 100 mL solution of 2-Morpholinoethanesulphonic acid (MES) was purchased from 
Sigma-Aldrich (St. Louis, MO) and was diluted with DI water to obtain a 100 mM MES 
solution.   Insulin, Recombinant Human (Catalog# 91077C-100MG) was purchased from Sigma-
Aldrich (St. Louis, MO). A 1 L standard solution of 0.1M Hydrochloric Acid (HCl) (Catalog# 
38280-1EA) was purchased from Sigma-Aldrich (St. Louis, MO) and diluted with DI water to 
obtain a 0. 01 M HCl solution. A 10 mg sample of insulin was mixed in a 20 ml solution of 0.01 
M HCl in a centrifuge tube to obtain an insulin stock solution. The stock solution was serially 
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 M.  The concentration of insulin antibody was calculated based on the coupling efficiency 
of MAI-Ab and magnetic microbeads. For MAI-Ab, with molecular weight 160 kDa, and a mass 
of 100 µg, with 85% coupling efficiency: 
Concentration of insulin antibody  
  (        )   (    )
       
 
   
                                               (4.1) 
For a 20 μL insulin sample with a concentration of 10
-5
 mol: 
Concentration of insulin   (       )       
   
 
                                                                 (4.2) 
The concentration of insulin antibodies used was 2.65 times more than the highest insulin 
concentration that was tested.  Figure 4.28 shows the process flow for insulin detection. 
 
Figure 4.28 Process flow for insulin detection using the fully integrated microfluidic system 
The fully integrated device was first treated with Pluronic solution for 2 hours to make the 
PDMS surface hydrophilic and also reduced any non-specific protein binding. The micropump 
was operated at a flow rate of 2 μL/min and the micromixer was operated at 10 Hz, 20 psi 
conditions. A 20 μL sample of MBAC and 20 μL of insulin sample were introduced 
simultaneously in their respective inlets and pumped to the mixing chamber. A permanent 
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magnet placed below the IDE was used to attract the MBAC and hold them close to the surface 
of the electrodes. A 20 μL solution of MES introduced at the inlet and a flow rate of 10 μL/min 
was used to wash away any unbound insulin within the mixing chamber. The wash step was 
repeated twice. After the wash step, impedance measurement was made by following a 







































5. RESULTS AND DISCUSSIONS 
This chapter presents and analyzes the experimental results and numerical simulation. The first 
section presents the results of the performance testing for the three pump designs. Specifically, 
the variation of flow rate with respect to actuation frequency and compressed air pressure is 
analyzed. The experimental results are compared with the results of a 2D COMSOL simulation 
of the micropump. The second section discusses the qualitative and quantitative performance of 
the micromixer. The qualitative testing was based on mixing of two colored dyes with respect to 
time. The quantitative testing was based on mixing efficiency determination for biotin-
streptavidin bead conjugation reaction with respect to actuation frequency, flow rate and 
compressed air pressure. The third section discusses the magnetic microbead separation scheme 
using permanent magnets and electromagnets of various sizes and magnetic strengths. The fourth 
section discusses the testing of the integrated microfluidic system for detection of biotin coated 
beads and insulin. 
5.1 Performance of Micropumps 
The performance characteristics of the three micropump designs were experimentally 
determined. The two main control parameters that affect the performance of the micropump are 
the compressed air pressure and the actuation frequency of the solenoid valve. 
5.1.1 Repeatability of Flow Rate 
For each design, the variation of flow rate within an individual micropump when tested three 
times and variation of flow rates between three separate micropumps was determined. Figure 5.1 
shows the variation in average flow rate within a single Design1 micropump when tested three 
times. Figure 5.2 shows the variation in average flow rate between three micropumps of 
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Design1, each tested three times. The mean variation in flow rate for a micropump of Design 1 
was 4.6%, with a maximum variation of 6.5% and a minimum variation of 1.54%.  The mean 
variation in flow rates between three micropumps of Design1 was determined to be 8.25%, with 
a maximum variation of 19.7% and a minimum variation of 1.3%.  
 
Figure 5.1 Flow rate variations within a single Design1 micropump 
 
Figure 5.2 Flow rate variations between three different micropumps of Design1 
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Figure 5.3 shows the variation in average flow rate within a single Design2 micropump when 
tested three times. Figure 5.4 shows the variation in average flow rate between three micropumps 
of Design2, each tested three times. 
  
Figure 5.3 Flow rate variations within a single Design2 micropump 
 
 
Figure 5.4 Flow rate variations between three different micropumps of Design2 
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The mean variation in flow rate for a micropump of Design2 was 2.9%, with a maximum 
variation of 6.0% and a minimum variation of 0.75%.  The mean variation in flow rates between 
three micropumps of Design2 was determined to be 10.6%, with a maximum variation of 17.4% 
and a minimum variation of 1.75%. Figure 5.5 shows the variation in average flow rate within a 
single Design3 micropump when tested three times. Figure 5.6 shows the variation in average 
flow rate between three micropumps of Design3, each tested three times. The mean variation in 
flow rate for a micropump of Design3 was 1.9%, with a maximum variation of 5.4% and a 
minimum variation of 0.8%.  The mean variation in flow rates between three micropumps of 
Design3 was determined to be 10.3%, with a maximum variation of 17.3% and a minimum 








Figure 5.6 Flow rate variations between three different micropumps of Design3 
The variation in flow rates from one pump to another of the same design can also be attributed to 
variations in the thickness of the PDMS membrane between micropumps. The variation in 
thickness of the PDMS membrane is due to the non-uniformity of the SU-8 film thickness 
obtained by the spin coating process step in fabrication of the SU-8 mold used for casting 
PDMS. A DekTak profilometer measurement indicated that the SU-8 film thickness varied 
between 90 – 100 µm at different locations on the wafer.  
After the completion of the micropump performance testing for all three designs, Design 3 was 
selected to be incorporated into the fully integrated microfluidic system. Among the three 
micropump designs, Design 3 was observed to have the highest flow rate (16 µL/min at 20 Hz, 
30 psi operating conditions) with the lowest mean variation in flow rate. The fabrication yield 
with Design 3 was also observed to be higher than other designs. The circular air chamber 
geometry used in Design3 provides an advantage over the rectangular air chamber geometry with 
sharp corners used in Design1 and Design2. The circular geometry of Design 3 air chambers 
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enables an easier release of the cured PDMS without any tear while being removed from the SU-
8 mold during the fabrication process. In case of Design1 and Design2, the cured PDMS tends to 
tear at the corners causing a reduction in the yield per wafer. 
5.1.2 Peak Flow Rate 
The micropump performance test results indicate that at a constant pressure, the flow rate 
increases with an increase in actuation frequency until a peak flow rate is reached and is 
followed by a drop in flow rate at higher frequencies. The frequency at which the peak flow rate 
is observed is referred to as the optimal frequency. The average peak flow rates observed with 
Design1, Design2 and Design3 micropumps are 12.75 µL/min (at 30 psi, 15 Hz), 10.75 µL/min 
(at 30 psi, 15 Hz) and16.0 µL/min (at 30 psi, 20 Hz) respectively. The maximum flow rate at a 
constant pressure depends on the fill and release time of the compressed air within the air 
chambers. The actuation frequency used to cycle the compressed air pressure controls the time 
available for the pressure inside the air chambers to change with time. If the frequency of 
operation is too high, there is not enough time for the air chambers to be completely filled and 
released and the flow rate decreases. If the operation frequency is too low, the number of pump 
cycles would also be low with idle time in between cycles, leading to lower flow rates even 
though the air chambers would have enough time to reach the actuation pressure. It was observed 
that the peak flow rate for the various designs increased with pressure. For Design3, the peak 
flow rate increased by 30% when the pressure was increased from 10 psi to 20 psi. The 
deflection of a PDMS membrane is directly proportional to the applied pressure. As the applied 
pressure is increased the deflection of the PDMS membrane increases and causes more fluid 
volume to be displaced, resulting in an increased flow rate.  
114 
 
These results of flow rate variation with respect to actuation frequency, with a peak flow rate at 
an optimal frequency, are similar to some of the previously reported peristaltic micropumps. A 
peristaltic micropump with piezoelectric actuation [168] has been reported to have a similar flow 
rate dependency on frequency. The flow rate was observed to increase with frequency until a 
peak flow rate of 25 µL/min was attained at an optimal frequency of 200 Hz, followed by a drop 
in flow rates for all higher frequencies. Similarly, a single stroke peristaltic PDMS micropump 
has been reported [169] with the flow rate increasing with frequency until a peak flow rate of 4 
µL/min was observed at an optimal frequency of 15 Hz, followed by a drop in flow rate for all 
higher frequencies.  The micropumps were tested over a period of three months without any 
failure. The durability of the micropump would mainly depend on the fracture of the PDMS 
membranes. However, PDMS is a highly resilient polymer material [170] and the performance of 
the micropump is satisfactory as long as the operating conditions are well regulated. 
5.2 Micropump Simulation - Equivalent Circuit Analysis  
In order to better explain the results of the micropump performance with the existence of a peak 
flow rate, an equivalent circuit simulation and COMSOL simulation was carried out. The 
purpose of the equivalent circuit analysis is to determine the time delay between the sequential 
actuation of the four PDMS membranes. The micropump system was converted into an 
equivalent electrical circuit and then analyzed using the SPICE analog circuit simulation 
software.  
The equation governing a mechanical system [171] can be written as  
   
  
  
     ∫                                                                                                             (5.1) 
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where F, υ, m, α and k are the force, velocity, mass, friction coefficient and stiffness 
respectively. 













) ∫                                                                                            (5.2) 
where P, ϕ and S are the  pressure, flow rate and area normal to flow direction respectively. 
Equation 5.2 is similar to a series RLC circuit with an equation [171] as below 
   
  
  
    
 
 
∫                 (5.3) 
where e, L, i, R, C are voltage, inductance, current, resistance and capacitance respectively. 
Comparing equations 5.2 and 5.3, an analogy between fluidic system and an electrical system 
can be obtained as shown in Table 5.1 [171] 
 
Mechanical/Fluidic Parameters Equivalent Electrical Parameters 
Φ          flow rate i         Current 
P           pressure e        Voltage 
m/S2     (where m is mass) L       Inductance 
α/S2      (where α is friction coefficient) R       Resistance 
k/S2      (where k is the stiffness) C       Capacitance 
 
Table 5.1 Mechanical/Fluidic parameters and their electrical analogues. 
Hydraulic resistance (Rhyd) represents energy dissipation due to fluid’s viscous friction against 
component’s wall and is calculated by integrating the velocity profile over the cross-sectional 
area of the channel such that flow rate as a function of pressure drop is known [172].  Hydraulic 
resistance depends on the channel geometry. For a channel with rectangular cross-section, Rhyd is 
calculated as [172] 
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                                                                                    (5.4) 
 where l is channel length, a is half channel width, b is half channel height and µ is fluid 
viscosity. The hydraulic capacitance (Chyd) represents the elastic behavior of the microfluidic 
component and relates the pressure difference to volume variation [173]. This variation is due to 
both the deformation of the structure and the elastic property of the fluid [173]. Chyd for a 
polymer membrane is given by 
      
(     )   
       
                                                                                                                       (5.5) 
where a is the side length of the membrane, S is the shape factor,   is the Poisson’s ratio, t is the 
membrane thickness, and E is the Young’s modulus of the membrane. A compressed air source 
applying pressure on the PDMS membrane is equivalent to applying a voltage to a node on the 
equivalent circuit. The compressed air pressure can be represented by a voltage source in the 
equivalent circuit. 
5.2.1 Transient Response of the Equivalent Circuit 
The time-phased sequential deflection of the PDMS membranes with interconnecting 
microchannels when actuated by a single compressed air source can be modeled by a parallel RC 
circuit. The RC circuit can be modeled by replacing the chambers and the membranes with 
electrical capacitors (C1, C2, C3 and C4) and the interconnecting microchannels with the 
electrical resistors (R1, R2, R3 and R4).  The compressed air source connected to the inlet of the 
air chambers through a solenoid valve controlled by square wave voltage signal can be replaced 
by a square pulse voltage source Vin. Table 5.2 shows the calculated values of resistances and the 






Table 5.2 Equivalent circuit component values for Design 3 
 
Figure 5.7 Equivalent circuit representation of a micropump with four PDMS membranes 
Each of the four air chambers of the micropump have a different time constant because of the 
pressure loss of the compressed air along the interconnecting microchannel and the deflection of 
the membranes. According to the equivalent circuit analogy described in the previous sections, 
the PSPICE solution for voltage across each capacitor in the equivalent circuit is analogous to 
the actual pressure inside the corresponding air chamber. The results of the PSPICE transient 
response analysis of the equivalent circuit for 10 psi, 20 Hz operating conditions is shown in 
Figure 5.8. The plot is normalized against the source voltage and the period of the cycle. The 
first half of the plot (from t=0 to t=0.025 s) represents the charging of the capacitor (analogous to 
air pressure increasing within air chamber) and the second half of the plot represents the 
discharging of the capacitor (analogous to air pressure reducing within the air chamber). During 
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the first half of the plot (upstroke), the air pressure within each chamber rises from atmospheric 
pressure and gradually approaches the source pressure. It can be seen from the upstroke pressure 
curves that the air chambers fill up in a sequence, air chamber 1 filling up first, followed by air 
chambers 2, 3 and 4, leading to a peristaltic motion. At one time constant, which is the time 
taken by the capacitor to charge to 63% of its fully charged voltage, the time delay between the 
first, second and third air chambers is 3 ms, 1ms and 1ms respectively. The deflection of the 
PDMS membrane is directly proportional to the pressure inside the chamber and therefore the 
deflection curves for the membraness would have a similar trend as the pressure curves. Since 
the Chamber 1 has a much higher time constant than the rest of the chambers, the membrane in 
the Chamber 1 would deflect first and therefore also function as a valve that reduces any 
backflow. During the second half of the plot (downstroke), the pressure within the air chamber 
gradually drops from the source pressure to the atmospheric pressure. It can be seen from the 
downstroke pressure curves that the air chambers empty in a sequence. 
 
Figure 5.8 PSPICE transient response of the equivalent circuit 
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5.3 Micropump Simulation - COMSOL  
The time delay obtained from the equivalent circuit simulation was used in performing a 
COMSOL simulation to verify the flow rate trend of the micropump. A 2D finite element 
simulation of the micropump was performed using the MEMS module of COMSOL 
Mulitphysics
TM
. The MEMS module includes a fluid-structure interaction (FSI) interface.  The 
FSI interface couples fluid flow and solid mechanics using arbitrary Lagrangian-Eulerian (ALE) 
method to study the interaction between the fluid and the solid structure.   
The fluid flow is described by the Navier Stokes equations to solve for velocity field, u = (u, v), 




       [      (    (  ) )]    ((    )     )                                             (5.6) 
                                                                                                                                        (5.7) 
In the above equations, I represents the unit diagonal matrix. The Navier Stokes equations are 
solved on a freely moving deformed mesh. The co-ordinate system velocity is    (     )   
The structural deformations are solved using an elastic, non-linear geometry formulation to allow 
large deformations. The total force exerted on the fluid-solid boundary is given by: 
     {    ( (   (  )
 )}                                                                                          (5.8) 
where   is the normal vector to the boundary and    represents a sum of pressure and viscous 
forces. 
The 2D model of the micropump consists of three layers as shown in Figure 5.9. The lower most 
layer (shown in red) represents the rigid glass layer. The top most layer consists of a combination 
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of flexible PDMS membranes (M1, M2, M3 and M4 shown in blue) and rigid PDMS (shown in 
grey) layer. The middle layer represents the fluidic layer (shown in green). The width and the 
thickness of the four PDMS membranes were set to be 1500 µm and 100 µm respectively. The 
height of the glass layer and fluidic layer were set to 100 µm. The fluidic layer was assigned the 
material properties of water with density, dynamic viscosity as 1000 kg/m
3
 and 0.001 Ns/m
2
 
respectively. The glass layer was assigned material properties that include Young’s modulus, 





Figure 5.9 2D view of the micropump model with multiple layers 
The PDMS layers were assigned material properties [174] that include Young’s modulus, 
Poisson’s ratio, and density equal to 75 MPa, 0.49, and 920 kg/m
3 
respectively. Figure 5.10 
shows a snapshot of the properties tab in COMSOL for defining material properties.  
 
Figure 5.10 Material properties of PDMS 
Fluidic layer 




The boundaries of fluid layer in contact with the PDMS and glass layers were assigned a fluid-
solid interface boundary condition. The fluid layer domain was assigned a free deformation 
boundary condition. The boundaries of the PDMS membrane along the y-axis were assigned a 
fixed constraint. The boundaries of the rigid PDMS layers were assigned a fixed constraint. All 
the parameters including time period (t), frequency (f), fluidic channel width (W), fluidic channel 
height (H) and net force (F) were defined in the parameters settings under the global settings 
menu. Figure 5.11 shows a snapshot of the user input parameters tab in COMSOL. 
 
Figure 5.11 Definition of global parameters 
Three square waveform functions, namely wv1, wv2, wv3 and wv4 were defined under the 
definitions menu. Figure 5.12 shows a screen shot of the definition of the waveform wv1. These 
square waveform functions can be invoked with angular frequency, phase and amplitude as 
variable parameters. Four boundary loads, namely Boundary Load 1, Boundary Load 2, 
Boundary Load 3 and Boundary Load 4 were defined on the PDMS membranes M1, M2, M3 
and M4 respectively. The boundary loads were defined as time-dependent forces with total force 
defined as a product of the force and the respective square waveform function. For example, 
Boundary Load 1 was defined as       . The negative sign indicates that the force acts in 
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the negative y direction.  Figure 5.13 shows an example of boundary load definition. The mesh 
settings were defined to be free triangular with a default fine element size set for fluid dynamics. 
 
Figure 5.12 Waveform wv1 definition parameters and plot of waveform wv1 
 
Figure 5.13 Boundary load definition 
Figure 5.14 shows a close-up view of the mesh for the circled part of the model before and after 
deformation. A time dependent solver with 1 ms time stepping was used to obtain the solution 
for one time period. Figure 5.15 shows the change in displacement of the PDMS membrane 
plotted against the arc length of the PDMS membrane for various time instances, at 10 psi, 5 Hz 







(a) Before deformation 
 
(b) After deformation 




Figure 5.15 Membrane displacements vs. arc length of the membrane for various time instances 
Figure 5.16 shows the change in displacement of all four PDMS membranes (M1, M2, M3 and 
M4) plotted against the arc length of the PDMS membrane at time t=0.01s, at 10 psi, 20 Hz 
operating conditions.  It can be seen from the Figure 5.16 that there is a time delay between the 
deflections of the membranes. 
 









































At t = 0.01s, membrane displacement of M1, M2, M3 and M4 are 1.8 µm, 2.4 µm, 1.15 µm and 
0.06 µm respectively. Membrane M1 deflects first and functions as a valve to reduce the back 
flow. The membranes M2, M3 and M4 have the same dimensions and are subjected to the same 
compressed air pressure of 20 psi. However, they show different membrane displacements due to 
the time delay between the actuation of the three membranes. This sequential deflection of the 
PDMS membranes leads to peristalsis causing the fluid underneath to flow. The flow rate was 
calculated in the post-processing by defining boundary integral to integrate velocity at the outlet 
boundary. Figure 5.17 shows a comparison of the average experimental flow rate and simulation 
flow rate obtained at 10 psi for a frequency ranging from 5 to 35 Hz.  
 
Figure 5.17 Experimental and simulation flow rates variation with frequency 
The simulation flow rate with respect to frequency has a similar trend as that of the experimental 
results. The flow rate increases with frequency to reach a peak value at an optimum frequency, 
followed by a drop in flow rate for all frequencies higher than the optimum frequency. It can be 
observed from Figure 5.17 that in general the simulation flow rate results are higher than the 
experimental results. Also, the difference in simulation and experimental flow rates depends on 
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the frequency.  The simulation model did not include the effects of pressure drop caused by the 
microfluidic connectors and external tubing connected to the outlet of the micropumps. The 
simulation model also does not include the pressure drop caused by the air bubbles generated 
within the fluidic layer of the micropump. The fluidic layer of the micropump was surface 
treated with Pluronic F108 which helps to reduce the generation of air bubbles but not 
completely eliminate them. It was also observed during the micropump performance testing that 
more air bubbles were generated at higher frequencies. This can cause a considerable pressure 
drop at higher frequencies which can cause the experimental flow rates to drop significantly.  
5.4 Performance of Micromixers 
The performance characteristics of three micromixer designs were experimentally determined. A 
qualitative test was first performed to compare the active mixing with diffusion mixing that 
occurs naturally when no external mixing is performed. 
5.4.1 Qualitative Testing 
The performance of the mixer was qualitatively tested for mixing of two colored dyes. The time 
taken for active mixing was compared with time for mixing purely by diffusion. Figure 5.18 
shows the pictures of the dye mixing within the device by diffusion as time progresses. It takes 6 
min for the two dyes to mix and reach one uniform color. Figure 5.19 shows the pictures of the 
two dyes mixing within the device by active mixing caused by the deflecting membranes of the 
micromixer as time progresses.  It took only 20 s to complete the mixing process by active 
mixing and mixing time is 18 times shorter than mixing by pure diffusion. These results indicate 




                           
(a) t = 0 min                     (b) t = 2.5 min                (c) t = 4 min                   (d) t = 6 min 
Figure 5.18 Diffusion only mixing at various time instants 
           
  (a) t = 2 s                          (b) t = 10 s                       (c) t = 15 s                    (d) t = 20 s 
Figure 5.19 Active mixing at various time instants 
 
5.4.2 Comparison with Table Top Mixer 
The mixing process at micro scale using the micromixer was compared with the macro scale 
mixing using the table top mixer. A micromixer and a table top mixer were used to mix SCP 
beads and BCF beads in order to achieve a streptavidin-biotin conjugation reaction. The relative 
increase in conjugation reactions due to active mixing methods when compared to mixing by 
pure diffusion alone (control) is shown in Figure 5.20 for micromixer and a table top mixer. The 
intensity of fluorescence signal is a direct measure of the extent of mixing. Both micromixers 
and table top mixers resulted in a significant increase in fluorescence signal. This clearly 
indicates the need for active mixing on both micro and macro scale for streptavidin-bioin 
conjugation reaction, and confirms that agitation of the flow improves binding efficiency. Due to 
the absence of turbulence in microfluidic systems, unless some form of flow agitation by active 
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mixing is present, mixing can only happen by diffusion. In case of micromixers, there was a 45% 
increase in the fluorescence signal due to active mixing, whereas in case of the table top mixer, 
there was only a 15% increase. These results indicate that active mixing at micro scale can 
improve the mixing performance.  
 
Figure 5.20 Increase in binding efficiency using a micromixer and table top mixer 
5.4.3 Mixing Performance Variation with Frequency 
Figure 5.21 shows a normalized plot of the average RFU with respect to frequency for the three 
micromixer designs tested three times. The actuation frequency was varied from 5 – 20 Hz at a 
constant flow rate of 2 µL/min and a compressed air pressure of 20 psi. The mean variation in 
RFU with respect to average RFU for a micromixer of Design 3 was 3.3%, with a maximum 
variation of 4.2% and a minimum variation of 2.56%. The mean variation in RFU for a 
micromixer of Design 2 with respect to average RFU was 8.27%, with a maximum variation of 
13.03% and a minimum variation of 2.87%. The mean variation in RFU with respect to average 
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RFU for a micromixer of Design 1 was 12.9%, with a maximum variation of 15.3% and a 
minimum variation of 9.66%. Design 3 has the best mixing performance when compared to other 
designs during the frequency test. The peak RFU signal obtained for Design3 is 70% higher than 
Design2. In case of Design1, there was no significant change in RFU with change in frequency. 
 
 Figure 5.21 Normalized RFU vs Frequency for three mixer designs 
As the actuation frequency increases, the agitation within the mixing chamber increases and 
results in an increase in the streptavidin-biotin conjugation reaction until an optimal frequency is 
reached. The reduction in conjugation reaction at higher frequencies beyond the optimal 
frequency can be attributed to the response time of the membrane. At higher frequencies, there is 
insufficient time for the air chamber to be completely filled and exert pressure on the membrane 
to actuate it.  
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5.4.4 Mixing Performance Variation with Flow Rate 
The mixing performance was tested three times with respect to change in flow rate for the three 
micromixer designs. The flow rate range was varied from 1.2 – 4 µL/min at a constant frequency 
of 10 Hz and a constant compressed air pressure of 20 psi. Figure 5.22 shows the normalized plot 
of the average RFU with respect to flow rate for the three micromixer designs. 
 
 
Figure 5.22 Normalized RFU vs. Frequency for individual mixer designs 
It can be observed that the streptavidin-biotin conjugation reaction increases with the flow rate 
until it reaches a peak value. The mean variation in RFU with respect to flow rate for a 
micromixer of Design3 was 6.33%, with a maximum variation of 12.9% and a minimum 
variation of 3.13%. The mean variation in RFU with respect to average RFU for a micromixer of 
Design2 was 9.13%, with a maximum variation of 13.92% and a minimum variation of 4.82%. 
The mean variation in RFU with respect to average RFU for a micromixer of Design1 was 
10.29%, with a maximum variation of 14.29% and a minimum variation of 3.85%. 
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As the flow rate increases, the microbeads’ retention time in the mixer is reduced and the 
microbeads thus have less time to interact with each other, which reduces streptavidin-biotin 
conjugation reaction. However, at the lowest flow rate (1.2 µL/min), which corresponds to the 
largest retention time, the conjugation efficiency is the lowest. This is most likely due to the 
absence of recirculating eddies which occur only at higher Reynolds numbers (Re). The 
backwards flow and re-circulation of the fluid in these eddies allows more time within the 
mixing chamber for the beads to interact with each other and increases flow agitation, thus 
increasing streptavidin-conjugation reaction. At 1.2 µL/min, Re ~ 0.01 and the flow falls in the 
range of Stokes flow which closely follows the contour of the mixing chamber without 
recirculation. The recirculation phenomenon depends on the Reynolds number, and the channel 
geometry is the same for all designs. Therefore, the differences in designs do not significantly 
affect the flow rate at which peak mixing efficiency occurs.  The highest mixing performance 
was observed at 2 µL/min. Design3 has the best mixing performance with respect to flow rate. 
At 2 µL/min, the peak RFU value of Design3 is 70% higher than Design2. Design1 did not show 
any significant variation in performance with change in flow rate. Based on the highest 
performance of Design3 with respect to both frequency and flow rate, Design3 was selected to be 
incorporated into the fully integrated microfluidic system. 
Despite the numerous recent works on micromixers, characterization of micromixers still 
remains a challenge [175]. Micromixers are commonly characterized based on three 
nondimensional fluid parameters: Re, Péclet number (Pe), and Strouhal number (St) [176].  
Péclet number is a measure of the relative importance of advection and diffusion in providing the 
mass transport associated with the mixing. Pe is defined as 
     
  
 
                                                                                                                                     (5.9) 
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where U is the velocity of the fluid, L is the mixing path which is on the same order of the height 
of the mixing chamber in this study and D is the diffusivity of the fluids.  Strouhal number is 
generally associated with active mixers and represents the ratio between the residence time of a 
species and the time period of disturbance.  St is defined as: 
     
   
 
                                                                                                                                  (5.10) 
where f is the frequency of the disturbance action and Dh is the hydraulic diameter. The optimum 
mixing efficiency occurs at a frequency of 10 Hz and a flow rate of 2 µL/min.  The characteristic 
Pe, St and Re values of the micromixer to perform at the optimum mixing efficiency conditions 
were calculated to be 11.2, 17.5 and 0.02 respectively.  
A magnetic particle driven micromixer design has been reported [177] with a mixing 
performance dependence on driving frequency similar to the one observed in this study. The 
peak mixing efficiency was observed at an optimum frequency of 20 Hz.  A microfluidic 
electroosmotic mixer has been reported [178] with a study on the effect of frequency on the 
mixing efficiency.  The performance curve for variation of mixing efficiency with frequency, 
with a peak mixing efficiency at an optimum frequency of 22 Hz,  is similar to the one observed 
in this study.  
5.5 Performance of Integrated Micromixer and Micropump 
A micropump (Design3) and micromixer (Design3) were integrated on a single device to obtain 
an integrated micromixer-micropump and tested for mixing efficiency based on streptavidin 
biotin conjugation reaction. Mixing efficiency was calculated by comparing the RFU values of 
20 μL volumes of fluorescent bead sample with the RFU value of 20 μL of the post mixing 
sample after magnetic separation/washing step. Figure 5.23 (a) and (b) shows the normalized 
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plot of average RFU and mixing efficiencies for a frequency range of 5 to 25 Hz.  The mean 
variation in RFU with respect to average RFU is 4.08%, with a maximum variation of 5.4% and 
a minimum variation of 2.4%.  A maximum mixing efficiency of 83.3 % was observed at 10 Hz. 
 
                                 (a)                                                                                  (b) 
Figure 5.23 (a) Normalized RFU vs Frequency (b) Mixing efficiency vs Frequency 
Figure 5.24 (a) and (b) shows the normalized plot of average RFU and mixing efficiencies for a 
pressure range of 5 to 30 psi.  The mean variation in RFU with respect to average RFU is 6.7%, 
with a maximum variation of 10.5% and a minimum variation of 3.4%.  A maximum mixing 
efficiency of 82.8 % was observed at 20 psi.  Figure 5.25 (a) and (b) shows the normalized plot 
of average RFU and mixing efficiencies for a flow rate range of 1 to 6 μL/min.  The mean 
variation in RFU with respect to average RFU is 6.58%, with a maximum variation of 11.5% and 







                               (a)       (b) 
Figure 5.24 (a) Normalized RFU vs. pressure (b) Mixing efficiency vs. pressure 
 
                                 (a)                                                                               (b) 
Figure 5.25 (a) Normalized RFU vs. flow rate (b) Mixing efficiency vs. flow rate 
Based on the performance testing results, the optimum operating conditions for obtaining the 
highest mixing performance is 2 µL/min sample flow rate, 10 Hz actuation frequency and a 




5.6 Magnetic Microbead Separation Scheme 
The testing for magnetic microbead separation included both electromagnets and permanent 
magnets of various sizes and magnetic strengths.  
5.6.1 Electromagnets 
Three electromagnets of different size and strength, namely EM1, EM2 and EM3 were tested. In 
case of electromagnets EM1 and EM3, it was not possible to capture all the SCP beads even at a 
SCP bead sample flow rate of 1 μL/min. The magnetic field strength generated by EM1 and EM3 
was not sufficient enough to overcome the hydrodynamic drag force. In case of EM2, it was 
possible to capture SCP beads successfully up to a bead sample flow rate of 1.5 μL/min. The 
magnetic force exerted on the SCP bead was calculated using Equation 2.2 for all three 
electromagnets selected.  The hydrodynamic drag force on the SCP beads was calculated for 
various flow rates using Equation 2.3.  The hydrodynamic drag force for flow rates in the range 
of 1-10 μL/min and magnetic force exerted by three electromagnets is shown in Figure 5.26. 
  
Figure 5.26 Comparison of magnetic field strengths of electromagnets with drag force 
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It can be seen from Figure 6.18 that EM1 and EM3 can generate a magnetic force of 0.76 pN and 
0.73 pN which are not sufficient to overcome the hydrodynamic drag force of 1.4 pN at a flow 
rate of 1 μL/min. EM2 can generate a magnetic force of 2.6 pN which is enough to overcome the 
hydrodynamic drag force up to 1.5 μL/min. In case of EM2 which could be used up to 1.5 
μL/min, it was not possible to obtain repeatable results as the top surface of the electromagnet 
was not perfectly flat and it wasn’t possible to make a uniform contact with the bottom surface of 
the microfluidic system. The setup required a mini lab jack to raise the electromagnet and bring 
it in contact with the device under test and was also very sensitive to any movements of the 
device while in operation. The large diameters of the electromagnet would also require the 
microfluidic connectors to be placed wider apart to provide enough space to position the 
electromagnets in contact with the mixing chamber of the device. The electromagnets tested had 
insufficient magnetic field strengths and even when successful at very flow rates could not 
provide repeatable results. Due to these limitations and disadvantages, the electromagnet 
approach to capture SCP beads was not suitable. 
5.6.2 Permanent Magnets  
 Three permanent magnets of various size and strengths, namely PM1, PM2 and PM3 were 
tested. In case of permanent magnet PM3, it was possible to capture the SCP beads up to a 
sample flow rate of 1.5 μL/min. In case of permanent magnets PM1 and PM2, it was possible to 
capture the SCP beads up to 10 μL/min. The hydrodynamic drag force and magnetic force 
exerted by the permanent magnets was calculated using Equation 3.1 and Equation 3.2 
respectively. Figure 5.27 shows that PM3 can generate a magnetic force of 2.05 pN which can 
overcome the hydrodynamic drag force up to a flow rate of 1.5 μL/min only. PM1 and PM2 can 
137 
 
generate a magnetic force of 16.5 pN and 24.0 pN  respectively and can overcome the 
hydrodynamic drag forces up to 10 μL/min. 
 
Figure 5.27 Comparison of magnetic field strengths of permanent magnets with drag force 
Figure 5.28 (a) shows a top view of an empty mixing chamber of a microfluidic channel with a 
permanent magnet placed below it and before a bead sample was injected into the device. Figure 
shows the empty mixing chamber and mixing chamber with the trapped beads after the SCP 
beads were injected into the device at a flow rate of 10 μL/min.  The periphery of the circular 
mixing chamber can be seen and the group of trapped SCP beads appears with an orange shade 
in the Figure 5.28 (b). Based on these results, permanent magnet PM1 was selected for all 
magnetic separations within the microfluidic channel as the magnetic flux density was high 
enough to capture moving beads up to a flow rate of 10 μL/min. Also, the small size of PM1 
with a diameter of 4.8 mm and a thickness of 3.2 mm makes it compact and easier to integrate 





Figure 5.28 Images of the mixing chamber with a permanent magnet in the background (a) 
Before the beads were injected into the circular mixing chamber (b) after beads were injected 
with trapped beads (appears orange in color) inside the mixing chamber 
 
5.7 Integrated Microfluidic System Testing 
Two different testing protocols were employed to evaluate the performance of the integrated 
microfluidic system. In the first test, the integrated microfluidic system was used for detection of 
biotin coated microbeads. In the second test, the integrated microfluidic system was used for 
immune based microbead insulin detection. 
5.7.1 Impedance Detection of BCF Microbeads 
Impedance spectrum results are commonly represented in a Bode plot format, where the 
magnitude of the impedance (log scale) is plotted on the y-axis and frequency on the x-axis (log 
scale). Figure 5.29 shows the impedance spectrum (Bode plot representation) for all 
concentrations of BCF beads ranging from 1.9  105 to 4.8   106. The magnitude of impedance 
increased with increase in the number of BCF beads. In order to determine the frequency at 
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which the maximum change in absolute impedance between the BCF beads and the control was 
obtained, a curve was drawn between normalized impedance change (NIC) and frequency.  NIC 
was defined by the following equation: 
      
                 
        
                                                                                                    (5.11) 
where           is the absolute impedance of the control and          is the absolute impedance 
of the sample containing BCF beads.  
 
Figure 5.29 Impedance spectrum (Bode plot) for different concentrations of BCF beads 
 
 
As shown in Figure 5.30, the impedance change (represented by NIC) showed an increase from 
5% to 63% in the frequency range from 1 kHz to 80 kHz, remained constant at 63% in the 
frequency range from 80 kHz to 1 MHz, and then decreased from 63% to 3% at higher 
frequencies. A mid-frequency value of 200 kHz where a peak NIC was observed was selected to 
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compare the impedance changes for all concentrations of BCF beads. The magnitude of 
impedance measured (three replicates) at 200 kHz for different concentrations of BCF beads 
from 1.9×10
5
 beads to 4.8 × 10
6
 beads is shown in Figure 5.31. It can be observed that there is no 
significant difference in impedance between control (SCP beads) and concentrations 1.9 × 10
5
 
and 4.8 x 10
5
 microbeads.  The difference in impedance with respect to control for a 
concentration of 1.9 × 10
5
 microbeads and 4.8 × 10
5
 microbeads was 3% and 7% respectively. 
 
 
Figure 5.30 The difference in magnitude of impedance (represented by NIC) between 4.8  106 
BCF beads and control sample. NIC was calculated for the measurements in the range of 
frequency from 1 KHz to 10 MHz. 
 
 





 and 1.9 × 10
6
 microbeads was observed to increase linearly and was 16%, 32% and 63% 





. The lower detection limit for BCF microbeads is 1.9 x 10
6
 microbeads. The 
experimental data of an impedance biosensor for the detection of BCF beads attached to SCP 
beads is represented by an equivalent circuit as shown in Figure 5.32 [179-180]. The equivalent 
circuit consists of two double layer capacitors (CPE), one for each set of the electrodes, 
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resistance of medium (Rs), and a stray capacitance (Cs) connected in parallel. Constant phase 
element (CPE) is used to model the double layer capacitance of the electrodes. 
 
 
Figure 5.31 Magnitude of impedance at 200 kHz for various concentrations of BCF beads 
This is commonly favored over the use of a simple capacitor [181]. CPE accouns for the effect of 
ionic species on the capacitance near the surface of an electrode. Rs accounts for change in 
conductivity and charge transport across the bulk medium. Cs represents the stray capacitance of 
the impedance measurement system associated with electrodes, shielding, wiring and connecting 
cables and chrome adhesion layer between gold and glass. The total impedance of the equivalent 




Figure 5.32 Equivalent circuit for impedance measurement system 




|  |    √      
 
(     ) 
                                                                                                           (5.12) 
|  |    √
 
(     ) 
                                                                                                                     (5.13) 
 
      
   
 
  
   
 
  
                                                                                                                      (5.14) 
where Z1 and Z2  are the impedance of the two branches of the equivalent circuit containing (CPE 
  Rs   CPE)  and Cs respectively. Zview software (Scribner Associates Inc., Southern Pines, NC) 
was used to fit the experimental impedance data to the chosen equivalent circuit model. The 
fitting was performed by the software using complex non-linear least-square method. Figure 5.33 
shows the bode plot of the experimental and fitted data from Zview software based on equivalent 
circuit.  
There are three distinct regions in the impedance spectrum which correspond to the three types 
of elements in the equivalent circuit. The double layer region is in the low frequency range from 
10 Hz to approximately 30 kHz, where the double layer capacitance of the electrodes represented 
by CPE dominates the impedance signal. For frequency ranging from 30 kHz to 1 MHz, 
conductivity of the medium is the key factor and the bulk medium resistance determines the 
signal. At a frequency greater than 1MHz is the dielectric region where the signal is dominated 




Figure 5.33 Bode plots of the impedance spectra of experimental and curve fitted data of control 
in the frequency range 10 Hz to 10 Mhz. Solid lines indicate the experimental data and crosses 
indicate the fitted data obtained from Zview software based on the the equivalent circuit. (a) 
Magnitude of impedance (b) Phase angle in degrees  
 
 
The division of the impedance spectrum into three distinct regions can be further analyzed with 
the help of the phase angle spectrum shown in Figure 5.33 (b). An electrical current passing 
through a capacitor is phase shifted by −90° with respect to the applied voltage. The phase angle 
in a capacitance dominated region of the impedance spectrum is therefore close to −90°. The 
current passing through a resistor is always in phase with the applied voltage.  Therefore the 





in Figure 5.33 (b), the phase angle is close to −90° on both ends of the impedance spectrum, and 
close to 0° in the middle. It can thus be concluded that both the low and high frequency spectra 
are dominated by a capacitance while the mid frequency region by a resistance. The simulated 
values of Rs, CPE and Cs in the equivalent circuit for control sample and sample with 4.86 × 10
6
 
BCF microbeads are listed in Table 5.3.  These values were obtained by curve fitting the 
respective experimental impedance data to the equivalent circuit.   
Sample RS (kΩ) CPE (nF) CS(pF) 
Control 3.56 15.33 13.70 
4.86 × 10
6
 BCF beads 5.47 16.36 13.60 
Change (%) 53.65 6.72 0.73 
 
Table 5.3 Simulated values of Rs, CPE and Cs in the equivalent circuit for control sample and 
sample with 4.86 × 10
6
 BCF microbeads and their respective percentage changes with respect to 
control 
 
The presence of BCF microbeads increased the value of the bulk medium resistance by 53.65% 
when compared to the control sample. The presence of BCF microbeads increased the value of 
CPE by 6.72% when compared to the control sample. The value of Cs did not change 
significantly since the connecting wires, electrode chip and all other parameters in the system 
remained constant. The change in impedance due to the presence of BCF microbeads was 
dominated by change in the bulk medium resistance when compared to change in values of 
double layer capacitance and stray capacitance. 
5.7.2 Immuno Microbead Based Insulin Detection 
The procedure for determining the coupling efficiency of MAI-Ab and magnetic microbeads has 
been described in Chapter 3 under “Coupling efficiency determination”. The fluorescence values 
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measured for the provided BSA standards in the Quant-iT protein assay kit is shown in Figure 
5.34.  
 
Figure 5.34 RFU vs concentration of BSA standards 
 
Each data point is an average of three readings obtained by fluorescence measurements of three 
samples of each BSA standard.  A standard curve was obtained by fitting a straight line to the 
data points. The coupling efficiency CE was calculated to be 85% using the following equation 
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M is shown in Figure 5.35. The magnitude of impedance increased with an 




Figure 5.35 Impedance spectrum (Bode plot) for different concentrations of insulin 
 
 
As shown in Figure 5.36, the impedance change (represented by NIC) showed an increase from 
3% to 32% in the frequency range from 1 kHz to 28 kHz, remained constant at 32% in the 
frequency range from 28 kHz to 1 MHz, and then decreased from 32% to 1% at higher 
frequencies. A mid-frequency value of 100 kHz where a peak NIC was observed was selected to 
compare the impedance changes for all concentrations of insulin with respect to control. The 









Figure 5.36 The difference in magnitude of impedance (represented by NIC) between 10
-5
M 
insulin sample and control sample. NIC was calculated for the measurements in the range of 
frequency from 1 KHz to 10 MHz. 
 
 
Figure 5.37 Magnitude of impedance at 100 kHz for various concentrations of insulin 
 
Figure 5.38 shows the experimental and fitted data simulated from Zview software based on 
equivalent circuit. The simulated values of Rs, CPE and Cs in the equivalent circuit for control 
sample and sample with insulin concentration of 10
-5
M are listed in Table 5.4. These values were 






Figure 5.38 Bode plots of the impedance spectra of experimental and curve fitted data of control 
in the frequency range 10 Hz to 10 Mhz. Solid lines indicate the experimental data and crosses 
indicate the fitted data obtained from Zview software based on the equivalent circuit. (a) 
Magnitude of impedance (b) Phase angle in degrees  
 
Sample RS (kΩ) CPE (nF) CS(pF) 
Control 5.23 14.46 13.50 
10-5 M insulin 6.73 16.19 13.70 
Change (%) 28.68 11.96 1.48 
 
Table 5.4 Simulated values of Rs, CPE and Cs in the equivalent circuit for control sample and 
sample with 10
-5
M insulin and their respective percentage changes with respect to control. 
 
The presence of insulin increased the value of the bulk medium resistance by 28% when 





when compared to the control sample. The value of Cs did not change significantly (1.5%) since 
the connecting wires, electrode chip and all other parameters in the system remained constant. 
The change in net impedance due to the presence of insulin was dominated by change in the bulk 
medium resistance when compared to change in values of double layer capacitance and stray 
capacitance. 
It can be observed from Figure 5.37 that there is no detectable difference in impedance between 




M. The difference in average 




M is only 0.8% and 1 % respectively. In 






M there is a detectable difference with 







M was observed to increase linearly and was 10%, 19% 







M is 10%, 7% and 7% respectively. There is not a detectable difference in 




M when taking the variation with respect to 
the average impedance value into consideration. The lower detection limit is 10
-5
M with a 32% 
increase in the average impedance with respect to control. The total detection time was 20 
minutes. 
A multiwalled carbon nanotube/dihydropan (MWCNT/DHP) composite sensor for the 
electrochemical detection of insulin in a microphysiometer device has been reported [182]. This 
device has been reported to have a detection limit of 10
-6
M insulin, compared to the 10
-5
M 
detection limit achieved with the microfluidic system in this study. The microphysiometer device 
is more suitable for laboratory testing when compared to the fully integrated microfluidic system 
in the present study that can be used for point-of-care testing. The microphysiometer electrodes 
150 
 
had to be conditioned for 1 hour before any insulin testing. Also, the resistance of 
MWCNT/DHP film to shear force under flow conditions has been reported [182] to be a 
concern. The microelectode used for impedance detection in this study does not require any 

































The performance testing of the three micropump designs were successfully completed. The 
performance tests were performed to determine the flow rate variation with respect to actuation 
frequency and actuation pressure. The performance testing results indicated that the flow rate 
increased with frequency until a peak flow rate was observed at an optimum frequency. The flow 
rate dropped for frequencies higher than optimum frequencies. At frequencies below the 
optimum frequency, the flow rate increased with increasing pressure. The repeatability of flow 
rates within a micropump and also between multiple micropumps of each design was 
experimentally determined. The highest flow rate was observed in Design3 micropumps, with a 
peak flow rate of 16 µl/min at 30 psi, 20 Hz operating condition. The mean variation in flow rate 
for a micropump of Design3 was 1.9%, with a maximum variation of 5.4% and a minimum 
variation of 0.8%. The fabrication yield with Design 3 was also observed to be higher than other 
designs. Based on the performance test results, Design3 was selected for the fully integrated 
microfluidic system. In order to better explain the results of the micropump performance and to 
validate the trend of flow rate variation with actuation frequency, an equivalent circuit simulation 
and COMSOL simulation was carried out. The simulation and experimental results showed a 
consistent trend for flow rate variation with respect to frequency and the peak flow rate at an 
optimum frequency. 
The performance testing of three micromixer designs were successfully completed. Both 
qualitative and quantitative tests were performed. A qualitative testing based on mixing colored 
dyes indicated that the active mixing using a micromixer shortened the mixing time by 18 times 
when compared to mixing based on diffusion alone. The quantitative tests were performed to 
determine the mixing performance based on streptavidin-biotin conjugation reaction with respect 
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to flow rate and actuation frequency. The performance testing results indicated that the mixing 
efficiency increased with frequency until a peak mixing efficiency was observed at an optimum 
frequency. The mixing efficiency dropped for frequencies higher than optimum frequencies. The 
mixing efficiency was also observed to depend on the sample flow rates. The optimum flow rate 
for mixing efficiency was experimentally determined. The highest mixing efficiency was 
observed in Design3 micromixer, with an 85% mixing efficiency at an operating condition of 2 
µL/min, 10 Hz and 20 psi. Based on the performance test results, Design3 micromixer was 
selected for the fully integrated microfluidic system.  
 
A micropump (Design3) and micromixer (Design3) were integrated on a single device to obtain 
an integrated micromixer-micropump and tested for mixing efficiency based on streptavidin 
biotin conjugation reaction. Based on the performance testing results, the optimum operating 
conditions for obtaining the highest mixing performance was determined to be 2 µL/min sample 
flow rate, 10 Hz actuation frequency and a compressed air pressure of 20 psi. The micromixer 
was operated under these conditions for all further testing in the fully integrated microfluidic 
system. 
 The testing for magnetic microbead separation included both electromagnets and permanent 
magnets of various sizes and magnetic strengths.  Three permanent magnets and three 
electromagnets of different size and strength were tested for their suitability in magnetic 
separation of SCP microbeads flowing within a microfluidic system. It was experimentally 
determined that the magnetic field strength generated electromagnets was not sufficient enough 
to overcome the hydrodynamic drag force for flow rates in the range 1 – 10  µL/min. The test 
results with permanent magnet indicated that permanent magnet PM1 was suitable in separating 
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moving microbeads up to a flow rate of 10 μL/min. Also, the compact size of makes it easier to 
integrate within the microfluidic system without interfering with the microfluidic connectors. 
Multiple designs of IDE were successfully developed and tested for impedance spectrum 
measurements. A labVIEW plug and play instrument driver for HP4192A was downloaded from 
National Instruments website and modified to perform a log sweep. An impedance analyzer 
coupled with the labVIEW program was used to record the impedance spectrum measurements 
in a microfluidic system.   
A fully integrated microfluidic system with a micropump, micromixer and IDE was successfully 
developed for detection of biomolecules. The fully integrated microfluidic system was used to 
detect target BCF microbeads and insulin. The detection of BCF microbeads was based on 
streptavidin-conjugation reactions between SCP microbeads and target BCF microbeads. 
Impedance spectrum measurements were made for concentrations of BCF microbeads ranging 
from 1.9  105 to 4.8   106 microbeads. The lower detection limit for BCF microbeads was 
experimentally determined to be 1.9 x 10
6
 microbeads. The insulin detection was based on 
mixing MBAC with target insulin molecules to allow binding reaction between target insulin 
molecules and MAI-Ab, and followed by impedance spectrum measurements. Impedance 




M. The lower 
detection limit for insulin detection was determined to be 10
-5
M. The total detection time was 20 






7. FUTURE WORK 
Based on the results of the present study, some of the future work possibilities are discussed in 
the sections below. 
7.1 Parallel Processing 
The fully integrated microfluidic system can be expanded to enable parallel processing of 
different insulin concentration samples simultaneously. Also, multiple testing of a single insulin 
sample can be performed simultaneously to confirm the reliability of the results. 
7.2 Inclusion of Valves 
In the present study, a continuous flow microfluidic system was developed without any control 
valves. The inclusion of valves will be necessary for expanding the current design to perform 
parallel processing and will also provide better process control. For example, inclusion of valves 
in the micromixer mixing chamber would enable a closed system mixing and control over the 
residence time of the mixing species within the mixing chamber. 
7.3 Nanobeads 
The replacement of microbeads with nanobeads can make the reaction kinetics faster and 
improve the capture efficiency. The high surface to volume ratio of nanobeads can reduce the 
quantity of bead sample required. However, the magnetic separation of nanobeads would require 
higher magnetic field strength when compared to microbeads. 
7.4 COMSOL simulation 
A 3D COMSOL model can be implemented instead of the 2D model used in this study. Also, the 
model can be updated to include the effects of air bubbles within the microfluidic system and the 
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effects of pressure drop caused by the microfluidic connectors and external tubing on the 
microfluidic system. Also, COMSOL can be used for simulation of impedance change. 
7.5 PDMS Alignment System 
All the alignments between different layers of PDMS in the present study were performed by 
manual alignment with tweezers under a stereo microscope. The development of a rapid and 
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